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Introduction 
 
 
 
 
 
 
 
 
 
 
 
 
It is internationally recognized that breast milk is the best source of nutrition for 
infants, both from a hygiene and completeness of nutrient point of view.  Just 
before weaning and also immediately after, however, infants need to receive, in 
addition to breast milk, also supplementary food products to meet their growing 
nutritional needs. Furthermore, there are instances where breast milk may be in-
sufficient or not available and thus, may need to be supplemented or replaced. 
In those instances, nutrition consists of infant formula (liquid and powder), pre-
pared according to internationally recognized standards. 
The use of powdered milk requires a proper knowledge of the correct 
methods of preparation and hygiene risks that can arise from improper handling 
and storage, both at home and in the hospital. Indeed, unlike liquid infant formu-
la, which is sterilized by technological treatments applied before commercializa-
tion, the powdered formulations have a residual microbial flora generally com-
posed of saprophytic bacteria and Enterobacteriaceae. 
Cow's milk powder is not a sterile product and, once rehydrated, is a good 
breeding ground for microorganisms. The technology of production of infant 
formula basically follows the production of dried milk with spray-drying system, 
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except for slight changes the addition of nutritional complements, usually mixed 
with milk before heat recovery. 
The presence of these microorganisms in milk powder may occur in two 
ways: 
- contamination through the use of ingredients not subjected to heat 
treatment during the manufacturing process; 
- contamination during the so-called "dry" process passages, such as con-
tamination post heat treatment, typically during dehydration or packag-
ing of the product. 
Assuming that the heat treatment that the milk undergoes during the pro-
cess accomplishes a perfect recovery of the product from a microbiological point 
of view, the contamination will probably occur at some point between the spray-
drying and the packaging processes. Therefore, to prevent bacterial contamina-
tion of the finished product, it is critical the control of microorganisms of drying, 
post-drying and pre-packaging environments. 
 
Both FAO and WHO considered cases of illnesses in infants associated with 
powdered infant formula (PIF) consumption (FAO/WHO, 2004). In particular, a 
bacterium belonging to the genus Enterobacteriaceae has become more and 
more relevant: the Enterobacter Sakazakii (ES). 
Recently, the ICMSF (International Commission on Microbiological Specifi-
cations for Foods) has described the Enterobacter Sakazakii as "a serious threat 
to particular categories of people, for which the bacterium could compromise life 
or at least it could significantly impair the quality of life because of the after-
effects, even in the long term, due to infection". Therefore, this bacterium has 
been included among the most feared food-borne pathogens, like Listeria mono-
cytogenes, Clostridium botulinum type A and B and Cryptosporidium parvum. 
The FAO/WHO expert meetings have identified all infants (< 12 months of 
age) as the population at particular risk for E. Sakazakii (Cronobacter species) in-
fections. Among this group, those at greatest risk are infants less than 2 months 
of age, particularly neonates (< 28 days), particularly pre-term, low-birthweight 
(< 2500 g), and immunocompromised infants, and those less than 2 months of 
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age. The microorganism is easily able to overcome the gastric barrier and cause 
infection because the pH of the stomach of infants is less acid than that of adults. 
While the incidence of these E. Sakazakii (Cronobacter species) infections 
in infants appears to be low, the consequences can be severe. Reported fatality 
rates vary considerably with rates as high as 50 percent reported in at least one 
outbreak. In addition, a portion of surviving infants has permanent disabilities 
such as retardation and other neurological conditions.  
Among the infections caused by E. Sakazakii meningitis is the most severe 
form. In the advanced stages of the disease, the pathological manifestations 
most commonly observed are: ventriculites, brain abscesses, cysts, hydrocepha-
lus, quadriplegia, delayed mental development and cerebral infarction (Bar-Oz, 
Preminger, Peleg, Block, & Arad, 2001) (Lai, 2001). Another important pathologi-
cal neonatal manifestation caused by ES is the necrotizing enterocolitis (NEC). 
The prerequisites involved in the pathogenesis of this disease seem to be: neona-
tal intestinal ischemia, microbial colonization of the intestine and an increase of 
the protein substrate present in the intestine as can be derived from the as-
sumption of milk formulae (Lucas & Cole, 1990). The NEC is characterized by ne-
crosis and pneumatosis intestinalis and is the most common gastro-enteric dis-
ease of the newborn, with a mortality rate ranging 10-55% (Peter, et al., 1999). 
In industrialized countries sixty cases of infection and several deaths 
caused by ES infection among infants fed with milk powder have been reported. 
These cases have always led to the recall of the product from the market. In Italy, 
until now, have not been reported cases of infection from E. Sakazakii. However, 
the problem is so important that the National Institute of Health has recently 
published a report inherent the microbiological hazards associated with the feed-
ing of the newborn (Fiore, Casale, & Aureli, 2004).  
The International Commission on Microbiological Specifications for Foods 
(ICMSF) provided in 1974 urgently needed guidance on the use of sampling plans 
and Microbiological Criteria (MC) for foods in international trade (ICMSF, 1974). 
In particular, ICMSF proposed to use attribute sampling plans; these kind of plans 
are of two types: a two-class plan used to classify the test samples as “accepta-
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ble” or “defective” and a three-class plan used to classify the test samples as “ac-
ceptable”, “marginally acceptable” or “defective”.  
These sampling plans have been widely adopted by public and private par-
ties. They have been incorporated into specifications in commercial trading con-
tracts and have been included in food law in different countries (Legan, 2001). 
Assessing the compliance of a batch to a MC depends on the criteria of the sam-
pling plans. In general, two-class sampling plans are used when the health hazard 
is severe and direct (ICMSF, 1974) (ICMSF, 2002) (Legan, 2001). 
The EU (art. 4 CE n° 852/2004) impose the operators of the food industry 
to respect specific microbiological criteria. The EU n° 2073/2005 regulation on 
microbiological criteria applicable to food products requires that the search of 
Enterobacter Sakazakii has to be performed in “in dried infant formulae and 
dried dietary foods for special medical purposes intended for infants below 6 
months of age ". To this end, 30 sample units per lot must be analyzed during the 
period of shelf life of the product placed on the market. The results are consid-
ered satisfactory, if all the values observed indicate the absence of the bacterium 
and unsatisfactory, if the presence of the bacterium is detected in any of the 
sample units. To assess the hygiene of the production process the search of En-
terobacteriaceae is performed and it must be absent in 10 sample units of 10 g 
of product. The analysis is performed at the end of the manufacturing process. If 
Enterobacteriaceae are detected in any of the sample units, the batch has to be 
tested for E. Sakazakii and Salmonella. 
 
This dissertation is the outcome of a specific request made by a worldwide 
famous company, named “ACME” - we keep its name hidden for confidentially 
agreement with the management - that produces powdered infant formula. AC-
ME asked us to assess if the sampling procedures they adopt internally to decide 
if a batch can be released on the market is better (and how much better) than 
the one required by Law for the detection of ES contamination. 
 
In the first chapter, we present a short overview of Acceptance Sampling, 
given the importance that this type of quality control plays as an audit tool to en-
8 
sure that the output of a process conforms to specific requirements. In the sec-
ond chapter, we treat the problem of powdered infant formula and the way the 
microorganisms are physically distributed in foods. The third chapter is initially 
dedicated to the definition of Autosampling and Law Sampling procedures in the 
production of Powered Infant Formulae. The second part of the chapter discuss-
es the ACME company, their production process and the three questions the 
ACME management submitted to a Control Quality Organization about the validi-
ty of their sampling procedures. The chapter ends with a description of the data 
provided by ACME to answer the three mentioned questions. Chapter four is 
dedicated to the reconstruction of the analysis performed by the Control Quality 
Organization that has been serving ACME for many years, analysis that has been 
deemed unsatisfactory by the ACME management. With the results of the analy-
sis conducted on the basis of the procedures normally adopted in the literature 
on the subject, it was not possible to answer the questions addressed by the 
management. For this reason, in chapter five we propose a completely different 
and innovative approach to analyze the problem. The work ends with some pro-
posals to the management on what to do in the future to monitor the perfor-
mance of their PIF production process and to give better answers to their ques-
tions. 
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1 -  Lot-by-Lot Acceptance Sampling 
 
 
 
 
 
 
 
1. Lot-by-Lot Acceptance Sampling for Attributes 
Acceptance sampling is an important field of statistical quality control that was 
popularized by Dodge and Romig
1
 and originally applied by the U.S. military to 
the testing of bullets during World War II. If every bullet was tested in advance, 
no bullets would be left to ship. If, on the other hand, none were tested, mal-
functions might occur in the field of battle, with potentially disastrous results. 
Dodge reasoned that a sample should be picked at random from the lot, and on 
the basis of information that was yielded by the sample, a decision should be 
made regarding the disposition of the lot. In general, the decision is either to ac-
cept or reject the lot. This process is called Lot Acceptance Sampling or just Ac-
                                                          
 
 
1
 H. F. Dodge and H. G. Romig developed a set of sampling inspection tables for lot-by-lot inspec-
tion of product by attributes using two types of sampling plans: plans for lot tolerance percent 
defective (LTPD) protection and plans that provide a specified average outgoing quality limit 
(AOQL). For each of these approaches to sampling plan design, there are tables for single- and 
double-sampling. 
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ceptance Sampling. Acceptance sampling is concerned with inspection and deci-
sion making regarding products, one of the oldest aspects of quality assurance.  
Three aspects of sampling are important (Montgomery, 2009): 
1. It is the purpose of acceptance sampling to sentence lots, not to estimate 
the lot quality. Most acceptance-sampling plans are not designed for esti-
mation purposes; 
2. Acceptance-sampling plans do not provide any direct form of quality con-
trol. Acceptance sampling simply accepts and rejects lots. Even if all lots are 
of the same quality, sampling will accept some lots and reject others, the 
accepted lots being no better than the rejected ones. Process controls are 
used to control and systematically improve quality, but acceptance sam-
pling is not; 
3. The most effective use of acceptance sampling is not to “inspect quality in-
to the product” but rather as an audit tool to ensure that the output of a 
process conforms to requirements. 
Acceptance sampling is "the middle of the road" approach between no inspec-
tion and 100% inspection and is useful in several situation as  when testing is de-
structive, when the cost of 100% inspection is too high; when scheduling produc-
tion is compromised from 100% inspection etc. it is important to underline that 
the main purpose of acceptance sampling does not concern with the estimation 
of the quality of the lot but only with the decision whether or not the lot is likely 
to be acceptable 
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Advantages Disadvantages 
- It is usually less expensive because 
there is less inspection; 
- There is less handling of the prod-
uct, hence reduced damage; 
- It is applicable to destructive test-
ing; 
- Fewer personnel are involved in in-
spection activities; 
- It often greatly reduces the amount 
of inspection error; 
- The rejection of entire lots as op-
posed to the simple return of defec-
tives often provides a stronger mo-
tivation to the supplier for quality 
improvements. 
- There are risks of accepting “bad” 
lots and rejecting “good” lots; 
- Less information is usually generat-
ed about the product or about the 
process that manufactured the 
product; 
- Acceptance sampling requires plan-
ning and documentation of the ac-
ceptance-sampling procedure 
whereas 100% inspection does not. 
 
1.1 Types of Sampling Plans 
There are two major classifications of lot acceptance sampling plans (LASP): by 
attributes and by variables. The attribute case (attributes are quality characteris-
tics that are expressed on a “go, no-go” basis) is the most common for ac-
ceptance sampling. 
In a single-sampling plans one sample of items is selected at random from 
a lot and the disposition of the lot is determined from the resulting information. 
These plans are usually denoted as (n,c) plans for a sample size n, where the lot 
is rejected if there are more than c defectives.  
In a double-sampling plan, following an initial sample, a decision based on 
the information in that sample is: (1) accept the lot, (2) reject the lot, or (3) no 
decision. If the outcome is (3) a second sample is taken and the procedure is to 
combine the results of both samples and make a final decision based on that in-
formation.  
12 
A multiple sampling plans is an extension of the double sampling plans 
where more than two samples are needed to reach a conclusion. The advantage 
of multiple sampling is smaller sample sizes.  
A sequential sampling plans is the ultimate extension of multiple sampling 
where items are selected from a lot one at a time and after inspection of each 
item a decision is made to accept or reject the lot or select another unit. 
All these plans will be analyzed in depth in the following paragraph. 
 
The units selected for inspection from the lot should be chosen at random, and 
they should be representative of all the items in the lot. The random-sampling 
concept is essential in acceptance sampling. if random samples are not used, bias 
is introduced. The technique often suggested for drawing a random sample is to 
first assign a number to each item in the lot. Then n random numbers are drawn, 
where the range of these numbers is from 1 to the maximum number of units in 
the lot. This sequence of random numbers determines which units in the lot will 
constitute the sample. If products have serial or other code numbers, these 
numbers can be used to avoid the process of actually assigning numbers to each 
unit.  In situations where we cannot assign a number to each unit, utilize serial or 
code numbers, or randomly determine the location of the sample unit, some 
other technique must be employed to ensure that the sample is. Sometimes the 
inspector may stratify the lot. This consists of dividing the lot into strata or layers 
and then subdividing each strata into aliquots. Units are then selected from with-
in each aliquot. 
1.2 Lot Acceptance Sampling Plan Properties 
The choice of the type of plan depends on the characteristics and properties that 
the plan should have. An acceptance sampling plan can be characterized by: 
- Acceptable Quality Level (AQL): the AQL represents the poorest level of 
quality for the supplier’s process that the consumer would consider to be 
acceptable as a process average. The producer would like to design a 
sampling plan such that there is a high probability of accepting a lot that 
has a defect level less than or equal to the AQL;  
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- Lot Tolerance Percent Defective (LTPD): the LTPD is a designated high de-
fect level that would be unacceptable to the consumer. The consumer 
would like the sampling plan to have a low probability of accepting a lot 
with a defect level as high as the LTPD; 
- Type I Error (Producer's Risk): this is the probability, for a given sampling 
plan, of rejecting a lot that has a defect level less than or equal to the 
AQL. The producer suffers when this occurs, because a lot with accepta-
ble quality was rejected. The symbol α is commonly used for the Type I 
error and typical values for α range from 0.2 to 0.01; 
- Type II Error (Consumer's Risk): this is the probability, for a given sampling 
plan, of accepting a lot with a defect level greater than or equal to the 
LTPD. The consumer suffers when this occurs, because a lot with unac-
ceptable quality was accepted. The symbol β is commonly used for the 
Type II error and typical values range from 0.2 to 0.01; 
- Operating Characteristic (OC) Curve: this curve plots the probability of ac-
cepting the lot (Y-axis) versus the lot fraction or percent defectives (X-
axis). The OC curve is the primary tool for displaying and investigating the 
discriminatory power of a LASP; 
- Average Outgoing Quality (AOQ): a common procedure, when sampling 
and testing is non-destructive, is to inspect 100% of the rejected lots and 
replace all defectives with good units. In this case, all rejected lots are 
made perfect and the only defects left are those in lots that were accept-
ed. AOQ's refer to the long term defect level for this combined LASP and 
100% inspection of rejected lots process. If all lots come in with a defect 
level of exactly p, and the OC curve for the chosen LASP indicates a prob-
ability pa of accepting such a lot, over the long run the AOQ can easily be 
shown to be: 
( ) ( ) ( )1 0a a ap p N n p p p N nAOQ
N N
⋅ − + − ⋅ ⋅ −
= =
 
 
where N is the lot size; 
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- Average Outgoing Quality Level (AOQL): a plot of the AOQ (Y-axis) versus 
the incoming lot p (X-axis) will start at 0 for p = 0, and return to 0 for p = 1 
(where every lot is 100% inspected and rectified). In between, it will rise 
to a maximum. This maximum, which is the worst possible long term 
AOQ, is called the AOQL. 
- Average Total Inspection (ATI): when rejected lots are 100% inspected, it 
is easy to calculate the ATI if lots come consistently with a defect level of 
p. For a LASP with a probability pa of accepting a lot with defect level p, 
we have 
( )( )1 aATI n p N n= + − −  
where N is the lot size. 
- Average Sample Number (ASN): for a single sampling LASP (n, c) we know 
each and every lot has a sample of size n taken and inspected or tested. 
For double, multiple and sequential LASP's, the amount of sampling var-
ies depending on the number of defects observed. For any given double, 
multiple or sequential plan, a long term ASN can be calculated assuming 
all lots come in with a defect level of p. A plot of the ASN, versus the in-
coming defect level p, describes the sampling efficiency of a given LASP 
scheme. 
 
Making a final choice between single or multiple sampling plans that have 
acceptable properties is a matter of deciding whether the average sampling sav-
ings gained by the various multiple sampling plans justifies the additional com-
plexity of these plans and the uncertainty of not knowing how much sampling 
and inspection will be done on a day-by-day basis. 
1.3 Single-Sampling Plan for Attributes 
A single-sampling plan is defined by the sample size n and the acceptance num-
ber c (where a lot of size N has been submitted for inspection). Since the quality 
characteristic inspected is an attribute, each unit in the sample is judged to be 
either conforming or nonconforming. From a lot of size N, a random sample of n 
units is inspected and the number of nonconforming or defective items d ob-
15 
served. If the number of observed defectives d is less than or equal to c, the lot 
will be accepted. If the number of observed defectives d is greater than c, the lot 
will be rejected. Generally, a unit that is nonconforming to specifications on one 
or more attributes is said to be a defective unit. When we refer to this procedure 
we talk about a single-sampling plan because the decision about the rejection or 
acceptance of the lot is based on the information contained in one sample of size 
n. 
One way of picking (n,c) is to specify two desired points on the OC curve 
and solve for the (n,c) that uniquely determines an OC curve going through these 
points. The operating characteristic (OC) curve is one important measure of a 
LASP performance. It shows the probability that a lot submitted with a certain 
fraction defective will be either accepted or rejected. 
 
Suppose that the lot size N is large (theoretically infinite). Under this condi-
tion, the distribution of the number of defectives d in a random sample of n 
items is binomial with parameters n and p, where p is the fraction of defective 
items in the lot. An equivalent way to conceptualize this is to draw lots of N 
items at random from a theoretically infinite process, and then to draw random 
samples of n from these lots. This is the same way of sampling directly from the 
process. The probability of observing exactly d defectives is 
 
{ } ( ) ( ) ( )
!
 defectives 1
! !
n ddnP d f d p p
d n d
−
= = −
−
 
 
The probability of acceptance is simply the probability that d is less than or 
equal to c, or  
 
{ } ( ) ( )0
! 1
! !
c
n dd
a
d
nP P d c p p
d n d
−
=
= ≤ = −
−
∑   (1) 
 
The OC curve is developed by evaluating equation (1) for various values of 
p and shows the discriminatory power of the sampling plan. 
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Figure 1.1 - OC curve of the single-sampling plan n = 89, c = 2 
 
 
 
Figure 1.2 - Average outgoing quality curve for n = 89, c = 2 
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Figure 1.1 and figure 1.2 show, respectively, the OC curve and the AOQ 
curve for the sampling plan n = 89, c = 2. 
A sampling plan that discriminates perfectly between good and bad lots 
would have a degenerative OC curve that runs horizontally at a probability of ac-
ceptance Pa = 1.00 until a level of lot quality that is considered “bad” is reached; 
from that point the curve drops vertically to a probability of acceptance Pa = 
0.00, and then the curve runs horizontally again for all lot fraction defectives 
greater than the undesirable level. If such a sampling plan could be employed, all 
lots of “bad” quality would be rejected, and all lots of “good” quality would be 
accepted. 
Unfortunately, this kind of ideal OC curve is almost never be obtained in 
practice. It could be realized by 100% inspection, if the inspection were error-
free. The ideal OC curve shape can be approached, however, by increasing the 
sample size. Thus, the precision with which a sampling plan differentiates be-
tween good and bad lots increases with the size of the sample. The slope of the 
OC curve indicates  the discriminatory power (Figure 1.3).  
In figure 1.4 is shown how the OC curve behaves to the change of the ac-
ceptance number. Generally, changing the acceptance number does not dramat-
ically change the slope of the OC curve; the OC curve is shifted to the left or to 
the right. Plans with smaller values of c provide discrimination at lower levels of 
lot fraction defective than do plans with larger values of c. 
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Figure 1.3 - OC curves for different sample sizes 
 
Figure 1.4 - The effect of changing the acceptance number on the OC curves
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appropriate, then the sample size n and the acceptance number c are the solu-
tion to 
( ) ( )
( ) ( )
1 1
0
2 2
0
!1 1
! !
! 1
! !
c
n dd
d
c
n dd
d
n p p
d n d
n p p
d n d
α
β
−
=
−
=
− = −
−
= −
−
∑
∑
 
 
These two simultaneous equations are nonlinear so there is no simple, di-
rect solution. There are however a number of iterative techniques available that 
give approximate solutions.  
Typical choices for these points are: p1 is the AQL, p2 is the LTPD and α, β 
are the Producer's Risk (Type I error) and Consumer's Risk (Type II error), respec-
tively. 
1.4 Double, Multiple and Sequential Sampling Plans 
Double and multiple sampling plans were considered when a lot is questionable 
to give to this lot another chance.  
If in double-sampling the results of the first sample are not conclusive with 
regard to accepting or rejecting, a second sample is taken. Application of double 
sampling requires four parameters:  
n1 = sample size on the first sample 
c1 = acceptance number of the first sample 
n2 = sample size on the second sample 
c2 = acceptance number for both sample 
A random sample of n1 items is selected from the lot, and the number of 
defectives in the sample, d1, is observed. If d1 ≤ c1 the lot is accepted on the first 
sample. If d1 > c2 the lot is rejected on the first sample. If c1 < d1 ≤ c2, a second 
random sample of size n2 is drawn from the lot, and the number of defectives in 
this second sample, d2, is observed. Now the combined number of observed de-
fectives from both the first and second sample, d1 + d2, is used to determine the 
lot sentence. If d1 + d2 ≤ c2, the lot is accepted. However, if d1 + d2 > c2, the lot is 
rejected. 
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Respect to single-sampling, the double-sampling plan may reduce the total 
amount of required inspection. Suppose that the first sample taken under a dou-
ble-sampling plan is smaller than the sample that would be required using a sin-
gle-sampling plan that offers the consumer the same protection: the cost of in-
spection will be lower for double-sampling than it would be for single-sampling . 
It is also possible to reject a lot without complete inspection of the second sam-
ple (this is called curtailment on the second sample) (Montgomery, 2009). Con-
sequently, the use of double-sampling can often result in lower total inspection 
costs. Furthermore, in some situations, a double sampling plan has the psycho-
logical advantage of giving a lot a second chance. 
The potential disadvantages are: unless curtailment is used on the second 
sample, under some circumstances double-sampling may require more total in-
spection than would be required in a single-sampling plan that offers the same 
protection (thus, unless double-sampling is used carefully, its potential economic 
advantage may be lost); it is administratively more complex, which may increase 
the opportunity for the occurrence of inspection errors. 
 
A multiple-sampling plan is an extension of double-sampling. In multiple-
sampling plan more than two samples can be required to sentence a lot. If, at the 
completion of any n
th
 stage of sampling, the number of defective items is less 
than or equal to the acceptance number, the lot is accepted. If, during any stage, 
the number of defective items equals or exceeds the rejection number, the lot is 
rejected; otherwise the next sample is taken. The procedure continues until the 
last sample is taken and the lot disposition decision is made. The first sample is 
usually inspected 100%, although subsequent samples are usually subject to cur-
tailment. The construction of OC curves for multiple-sampling is a straightfor-
ward extension of the approach used in double-sampling.  
The principal advantage of this kind of plans is the smaller samples re-
quired at each stage in comparison with the other plans seen above; thus, some 
economic efficiency is connected with the use of the procedure. However, multi-
ple-sampling is much more complex to administer. 
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In sequential-sampling, we take a sequence of samples from the lot and al-
low the number of samples to be determined entirely by the results of the sam-
pling process. In practice, sequential-sampling can theoretically continue indefi-
nitely, until the lot is inspected 100%. In practice, sequential-sampling plans are 
usually truncated after the number inspected is equal to three times the number 
that would have been inspected using a corresponding single-sampling plan. If 
the sample size selected at each stage is greater than one, the process is usually 
called group sequential-sampling.  
In particular, if the sample size inspected at each stage is one, the proce-
dure is usually called item-by-item sequential-sampling.  
Item-by-item sequential-sampling is based on the sequential probability ra-
tio test (SPRT), developed by Wald (1947). The operation of an item-by-item se-
quential-sampling plan is illustrated in Figure 5. In the chart the cumulative ob-
served number of defectives is plotted. For each point, the abscissa is the total 
number of items selected up to that time, and the ordinate is the total number 
of observed defectives. With this plan another sample must be drawn only If the 
plotted points stay within the boundaries of the acceptance and rejection lines,. 
The lot is rejected if a point falls on or above the upper line and is accepted if  a 
sample point falls on or below the lower line.  
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Figure 1.5 - Graphical performance of sequential sampling 
 
The equations for the two limit lines for specified values of p1, 1-α, p2, and 
β are 
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The OC curve for sequential-sampling can be easily obtained. Two points 
on the curve are (p1, 1-α) and (p2, β). A third point, near the middle of the curve, 
is p = s and Pa = h2/(h1 + h2). 
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2 – Enterobacteriaceae in powdered infant formula 
 
 
 
 
 
 
 
2.1 Powdered formulae for infants and young children 
It is internationally recognized that breast milk is the best source of nutrition for 
infants. The World Health Organization recommends that infants should be ex-
clusively breast-fed for the first 6 months of life. However, there are instances 
where it may be insufficient or not available and thus it may need to be supple-
mented or replaced. In those instances, one of the dietary options is the use of 
powdered infant formulae (PIF). Infants who are not breast-fed should be pro-
vided with a suitable breast milk substitute, formulated in accordance with Co-
dex Alimentarius Commission standards. To reduce the risk of infection in infants 
fed PIF, recommendations have been made for the preparation and storage of 
PIF (D. Drudy, 2006). 
Breast milk substitutes are formulated to resemble the nutrient composi-
tion of breast milk and are a more satisfactory substitute for breast milk than any 
other product. Cow’s milk, which is used in the production of dried-infant formu-
la contains a higher amount of fat, protein and minerals than breast milk. There-
fore, it is first skimmed and then diluted in order to achieve levels more com-
monly found in breast milk.  
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Care must be taken in the manufacture of infant formula to safeguard the 
microbiological quality of the finished product. The manufacture of dried-infant 
formula can follow two procedures (M. Nazarowec-White, 1997). The ‘dry pro-
cedure’ involves dry mixing of ingredients into powder after spray-drying. This 
method should be avoided, as it can lead to bacteriological contamination 
(Lambert-Legace, 1982). In the second manufacturing method, dried-infant for-
mula is prepared using a ‘wet procedure’ where the following heat treatments 
are used: (1) liquid skim milk is heat-treated before processing at 82°C for 20 s; 
(2) the pre-mix consisting of skimmed milk and fat components is heat-treated at 
80°C for 20 s; (3) the total mixture containing all ingredients is heat-treated at 
107-110°C for 60 s; (4) the liquid mixture is concentrated using a falling film 
evaporator and (5) the concentrate is heat-treated again at 80°C and then im-
mediately spray-dried. Often, a combined procedure is used where water soluble 
components are added to the milk before drying and the less soluble compo-
nents are added to the blend after drying (Caric, 1993). 
As all dehydrated products, it is not possible using current technology to 
produce powdered formulae that are devoid of low levels of microorganisms, 
i.e., the products cannot be sterilized. Thus, their microbiological safety requires 
strict adherence to good hygienic practices during both manufacture and use. 
Both FAO and WHO considered cases of illnesses in infants associated with 
PIF consumption either epidemiologically or microbiologically (FAO/WHO, 2004). 
They identified three categories of microorganisms based on the strength of evi-
dence of a causal association between their presence in PIF and illness in infants 
(FAO/WHO, 2008):  
- microorganisms with a clear evidence of causality, namely, Salmonella 
enterica and Enterobacter Sakazakii2;  
                                                          
 
 
2
 Enterobacter Sakazakii is the microorganism whose name refers to the Japanese researcher 
Ricki Sakazakii for the great contribution he has given to the understanding of the biology of En-
terobacteriaceae and Vibrionaceae 
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- microorganisms for which the causality is plausible but not yet demon-
strated, i.e., they are well-established causes of illness in infants and 
have been found in PIF, but contaminated formula has not been con-
vincingly shown, either epidemiologically or microbiologically, to be the 
vehicle and source of infection, e.g., other Enterobacteriaceae;  
- microorganisms for which causality is less plausible or not yet demon-
strated, including microorganisms, which despite causing illness in in-
fants, have not been identified in PIF, or microorganisms which have 
been identified in PIF but have not been implicated as causing such ill-
ness in infants. 
2.2 Enterobacteriaceae in powdered formulae for infants and young children 
Salmonella is a well-known long-standing foodborne human pathogen. The inci-
dence of salmonellosis among infants, originating from various sources, was re-
ported to be more than eight times greater than the incidence across all ages in 
the United States of America (FAO/WHO, 2008). Infants are also more likely to 
experience severe illness or death from salmonellosis, and infants with immune 
compromising conditions are particularly vulnerable. It is unclear whether the in-
creased incidence of salmonellosis among infants results from greater suscepti-
bility, or whether infants are more likely than persons in other age groups to 
seek medical care or have stool cultures performed for symptoms of salmonello-
sis. At least 6 reported outbreaks of salmonellosis involving approximately 287 
infants have been associated with PIF between 1985 and 2005. Most of these 
outbreaks involved unusual Salmonella serotypes, which likely aided in recogni-
tion of those outbreaks. It is recognized that outbreaks and sporadic cases of 
salmonellosis due to powdered infant formula are likely to be under-reported 
(FAO/WHO, 2006). 
Enterobacter Sakazakii is a member of the family Enterobacteriaceae, ge-
nus Enterobacter, and is a motile peritrichous, gram-negative bacillus (J.J. Farmer 
III, 1980). The organism, which was initially referred to as “yellow-pigmented 
cloacae,” was reclassified as “E. Sakazakii” in 1980 on the basis of differences in 
DNA-DNA hybridization, biochemical reactions, pigment production, and antibi-
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otic susceptibility, compared with Enterobacter cloacae (J.J. Farmer III, 1980). En-
terobacter Sakazakii (Cronobacter species) has recently emerged as a pathogen 
of infants. The FAO/WHO expert meetings have identified all infants (<12 months 
of age) as the population at particular risk for E. Sakazakii  infections. Among this 
group, those at greatest risk are neonates (<28 days), particularly pre-term, low-
birthweight (<2500 g), and immunocompromised infants, and those less than 2 
months of age (FAO/WHO, 2006). E. Sakazakii was first implicated in a case of 
neonatal meningitis in 1958, when an outbreak in England resulted in the deaths 
of 2 infants. Since that time, there have been about 70 reported cases of E. Sa-
kazakii infection (M. Nazarowec-White, 1997).  
A listing of the reported cases and outbreaks of neonatal infections caused 
by E. Sakazakii found in the literature can be seen in Table 2.1. While the inci-
dence of E. Sakazakii infections in infants appears to be low, the consequences 
can be severe. The primary manifestations of E. Sakazakii infection in infants, i.e., 
meningitis and bacteraemia, tend to vary with age. E. Sakazakii meningitis tends 
to develop in infants during the neonatal period, while E. Sakazakii bacteraemia 
tends to develop in premature infants outside of the neonatal period with most 
cases occurring in infants less than 2 months of age. However, infants with im-
munocompromising conditions have developed bacteraemia as late as 10 
months of age and previously healthy infants have also developed invasive dis-
ease outside the neonatal period. Infections have occurred in both hospital and 
outpatient settings. It was noted that as older infants generally live at home in 
the community, infections in such infants may be more likely to be under-
reported. 
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Table 2.1 - Sporadic cases and outbreaks of Enterobacter Sakazakii infection for which pow-
dered infant formula (PIF) was implicated as the source agent (D. Drudy, 2006) 
 
 
Reported fatality rates of E. Sakazakii infections in infants vary considera-
bly with rates as high as 50 percent reported in at least one outbreak. Mortality 
rates of 33% – 80% have been reported (Lai, 2001). E. Sakazakii infections are al-
so associated with significant morbidity. Most children who survive Enterobacter-
associated meningitis (94%) develop irreversible neurological sequelae resulting 
in quadriplegia, developmental impedance, and impaired sight and hearing (D. 
Drudy, 2006). 
Although all known outbreaks have involved infants, sporadic cases have 
been reported in children and adults, however these have not been linked to PIF 
(FAO/WHO, 2004). 
 
PIF is not a sterile product, and current Codex Alimentarius Commission 
specifications for PIF permit 1–10 coliform bacteria per gram of formula. It 
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should be noted that E. Sakazakii belongs to this group of organisms. Neverthe-
less, PIF manufacturers implement a policy of zero tolerance for both Salmonella 
and Listeria species in products. Current drafting of microbiological specifications 
for E. Sakazakii is under consideration by the International Committee for the 
Microbiological Safety of Food and the Codex Alimentarius Commission (D. 
Drudy, 2006). 
There are four routes by which E. Sakazakii and Salmonella can enter PIF:  
1. through the ingredients added in dry mixing operations during the 
manufacturing of PIF; 
2. through contamination of the formula from the processing envi-
ronment in the steps during or following the drying; 
3. through contamination of the PIF after the package is opened; 
4. through contamination during or after reconstitution by the care-
giver prior to feeding.  
 
E. Sakazakii may be found in many environments such as food factories, 
hospitals, institutions, day-care facilities and homes. In manufacturing, the or-
ganism may gain access to the processing line and product, since current tech-
nology cannot completely eliminate this organism from the manufacturing envi-
ronment. 
2.3 Mechanisms influencing spatial distributions of microorganisms 
The distributions of how microorganisms are physically distributed in foods de-
termine both the likelihood that a foodstuff will cause illness and the consequen-
tial public health burden, but not much is known about these, yet.  
The spatial distribution of the microorganisms in foods determines the val-
ue of the data on prevalence and/or concentration, obtained through sampling 
and testing, for informing food safety management decision-making (e.g., for lot 
acceptance or for process control) and, ultimately, their value for determining 
the associated public health burden. Understanding spatial distributions of harm-
ful microorganisms is important for establishing proper microbiological criteria 
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and obtaining a realistic view of the performance of the associated sampling 
plans.  
 
Throughout the food processing, food products (from the raw material to 
the output) are exposed to a series of processes and related mechanisms that in-
fluence the level and spatial distribution of microorganisms. Usually there are six 
mechanisms (contamination, microbial growth, microbial death, joining, mixing 
and fractionation) that affects the final microbial distribution of a product (ILSI 
Europe, 2010). 
Contamination is the transfer of microorganisms onto a foodstuff from an 
external source. The contamination of foodstuffs generally occurs on the surface 
of a product, and often results in an uneven spatial distribution of microorgan-
isms. Contaminants are often coming from different sources (equipment and 
utensils, humans, water used for rinsing, cleaning and cooling, packaging materi-
als etc.) but also the contact with contaminated surfaces, air or water can cause 
the contamination. 
Once a food product has been contaminated, microbial growth can trans-
form an initially homogeneous distribution into a more clustered distribution on 
or within a foodstuff. In contrast with contamination, which occurs on external 
surfaces, growth can cause the distribution of microorganisms inside the prod-
uct. Often, during growth through reproduction, microbial cells form cell clumps 
or micro-colonies and this is due to particular growth characteristics of the mi-
croorganisms or to physical constraints of the food matrix. Different conditions 
of the product (for example cooling or thawing of the foodstuff) can cause mi-
crobial growth in different parts of the product and then an uneven distribution 
of microorganisms. 
As well as some situations may lead to microbial growth, some of the same 
situations can cause microbial death. In fact, situations of cooling or thawing, or 
the application of lethal processes or the adverse effects of changing environ-
mental conditions could lead to inhibition of microbial growth or (at lethal levels) 
even complete inactivation (death) of microbial cells.  
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Microbial death can result from the application of lethal processes (such as 
thermal processing or the addition of lethal levels of preservatives) or from the 
adverse effects of changing environmental conditions. Intrinsic product charac-
teristics (e.g., water activity, pH and nutrient availability), and extrinsic product 
characteristics (e.g., storage temperature or storage atmosphere). In this situa-
tion however is very unlikely that all the microbial cells die, so the final distribu-
tion of microbial cells would be even more clustered. 
Joining two or more materials (e.g., ingredients or food products), each 
with different microbial distributions, will result in a joined product with a distri-
bution, which is different from the initial microbial populations of the merged 
materials, but a function of the way in which joining occurs. 
When materials or product units are mixed, the original microbial popula-
tion is relocated throughout the product mass. In this situation, that can be an 
active process or the results of spontaneous movements, the spatial distribution 
is likely more random because, in general, mixing will disperse the microbial 
populations.  
Fractionation, like mixing, reallocates microorganisms over the resulting 
product units. Fractionation can also encompass procedures that may result in 
the removal of contaminating microorganisms, for instance when a portion of a 
food product is discarded or removed by peeling or rinsing. 
It is easy to understand how each of the mechanisms described may have 
an impact on the spatial distribution of microorganisms in a food. 
2.4 Stochastic distributions of microorganisms and clustering 
It is unlikely that every food portion of a larger bulk contains the same number of 
microorganisms, so the simple average number of microorganisms per portion is 
not an adequate representation of microbial status (ILSI Europe, 2010). But 
which is the right sizes of the portions and batches of interest? This information 
is necessary before considering distributions that might be used to model por-
tion-to-portion variation as well as overall average. The portion of interest differs 
from the perspective of public health or microbiological criteria (acceptance 
sampling plans). 
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On a very small scale, comparable to the size of a microorganism (perhaps 
10
-12
 cm
3
) there are only two kinds of portion, containing an organism or not, so 
that all possible distributions are clustered. Conversely, large portions can be ex-
pected to “average out” small scale clustering, but to reveal larger scale cluster-
ing, for example by production runs or production within a particular country. In 
principle, the presence of clustering can be defined, independently of scale, in 
terms of the probability of points (organisms) depending on the presence of 
nearby points. The distribution is deduced from, and its effect mediated by, 
numbers (or presence) in finite-sized samples. 
From the perspective of public health, the portion of interest is that which 
is actually consumed and could determine the exposure of individual consumers. 
The batch of interest is that which might be the subject of a risk assessment or 
be responsible for an outbreak. In an industrial setting, usually ranges from one 
to hundreds of tons. 
In the case of acceptance/rejection, the portion of interest is the amount 
analyzed, often smaller than the sample taken. The batch of interest is that sub-
ject to the acceptance/rejection decision, probably of the order of tons. 
For this kind of analysis portions range from 0.1 g to 500 g within batches 
of tons. 
 
The final distribution of microorganisms in a food is usually the result of 
multiple distinct mechanisms and is often a mixture of simpler distributions. 
Physical or spatial distributions are different from, although related to, fre-
quency distributions. The differences and relationships are illustrated in Figure 
2.1, Figure 2.2 and Figure 2.3 (ILSI Europe, 2010). Three different spatial distribu-
tion of 100 points over 25 portion are represented in Figure 2.1; chart (a) shows 
points quite regularly spread, chart (b) represents a very clustered situation and 
chart (c) shows points randomly spread (the distributions are represented in two 
rather than three dimensions for illustrative purpose). 
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Figure 2.1 - Three different spatial distribution of 100 points over 25 portions 
a) almost regular  b) one cluster  c) random 
 
 
Figure 2.2 - Numbers of points in individual portions for the three spatial distributions depicted 
in Figure 2.1 
a) almost regular  b) one cluster  c) random 
4 4 4 4 4  0 0 0 0 0  2 5 1 2 3 
4 4 4 4 4  0 1 0 4 9  4 4 2 5 3 
4 4 4 4 4  0 0 0 21 40  5 7 6 6 6 
4 4 4 4 4  0 0 0 8 16  2 3 1 5 5 
4 4 4 4 4  0 0 0 0 1  5 5 3 6 4 
 
 
Figure 2.3 - Frequency distributions for the three spatial distributions depicted in Figure 2.1 and 
Figure 2.2 
a) almost regular  b) one cluster  c) random 
 
 
In the food industry, each portion could be considered a ‘unit’ and the set of 25 
portions a ‘lot’, so Figure 2.1 and Figure 2.2 represent ‘within-a-unit’ and ‘within-a-
lot’ variation. Alternatively, each portion could be considered a lot so the figures 
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represent ‘within lot’ and ‘between lot’ variation. In Figure 2.2 it is shown the 
number of points belonging to each portion and Figure 2.3 shows the resulting 
frequency distributions. Figure 2.1 is the one that contains most information be-
cause it contains the spatial distributions of points and so the location of the 
points (not the values). This means that Figure 2.2 and Figure 2.3 can be deduced 
from Figure 2.1, but not vice versa. Figure 2.2 (spatial distributions of values) 
contains values (the concentrations in each portion) and locations (of portions, 
not of individual points). Figure 2.3 (frequency distributions) contains infor-
mation on values, but no information on location. Thereof it follows that the 
same frequency distribution may come from different spatial distributions. 
It is possible to characterize a spatial distributions by stating how the 
chance of finding a point depends upon the closeness of other points. So we 
have to analyze some of the terms often used in spatial distributions: ‘regular’, 
‘clustered’ and ‘random’. Regular distributions (e.g., Figure 2.1a) are not so usual 
in food microbiology but they can occur where contamination follows more or 
less regular patterns: in this situation points are less likely close to other points, 
so that points are relatively far apart from each other. Clustered distributions 
(e.g., Figure 2.1b) are instead quite common in food microbiology because con-
tamination often occurs in clusters, due to initial contaminants multiplying into 
micro-colonies, localized growth of microorganisms in non-liquid foods, etc. 
Points are here more likely close to other points, so that points are relatively 
close to each other. Uniform random distributions (e.g., Figure 2.1c) sometimes 
result from other patterns by perfect mixing. Points are equally likely close to or 
far from other points and the chance of finding a point is independent from the 
others points and the closeness to them. While the points in a random pattern 
are equally likely everywhere (so, the distribution of probability is uniform), they 
cannot actually be everywhere (so, the distribution of points is not uniform). Uni-
form random patterns are quite common in food microbiology, for instance in 
the case of well-mixed liquids or powders (ILSI Europe, 2010).  
To describe spatial distributions in quantitative terms can be quite difficult; 
the statistics of ‘spatial processes’ is sophisticated. Several approaches could be 
used. For instance, the positions of the points could be described by their X-Y co-
ordinates, or by the distances between neighboring points. One way of charac-
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terizing spatial distributions is by stating how the chance of finding a point de-
pends upon the closeness of other points. 
What is the information available in the real situations of food industry? 
Data describing actual spatial positions of individual microorganisms (e.g., as in 
Figure 2.1) contains most information, as mentioned above, but such infor-
mation is very rarely available. Data describing spatial positions of portions and 
their concentrations (e.g., as in Figure 2.2) contains some direct spatial infor-
mation that can be converted to frequency distribution form. Also this kind of in-
formation is not common and where it is available, the concentration data is of-
ten presence/absence rather than counts. As often as not data are available only 
in frequency distributions form (e.g., as in Figure 2.3), without any spatial con-
tent. So the only information available is how often particular concentrations 
were observed. Again, the concentration data is often presence/absence rather 
than counts, so that histograms such as Figure 2.3 would have only two bars, 0 
and >0. 
When we use the word ‘dispersed’ we need to know that it can assume dif-
ferent and opposite meanings depending if we are describing spatial or frequen-
cy distributions. Indeed, the most spread out spatial distribution (Figure 2.1a) 
gives the smallest variation in points per cell, while the most compact spatial dis-
tribution (Figure 2.1b) gives the greatest variation and the intermediate spatial 
distribution (Figure 2.1c) gives an intermediate variation. So, “a more dispersed, 
less clustered, spatial distribution gives a less dispersed, more clustered, fre-
quency distribution” and otherwise “a less dispersed, more clustered, spatial dis-
tribution gives a more dispersed, less clustered, frequency distribution” (ILSI 
Europe, 2010).  
 
The degree of spatial clustering can often be assessed by comparing the 
variance and mean of the corresponding frequency distributions. Generally, a 
regular spatial distribution has a frequency distribution with variance smaller 
than its mean; a clustered spatial distribution has a frequency distribution with 
variance greater than its mean and a uniform random spatial distribution has a 
frequency distribution with variance equal to its mean. 
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Table 2.2 (ILSI Europe, 2010) - Relationship between spatial and frequency distributions 
Spatial  
distribution  
(relative to  
uniform  
random) 
Frequency distribution (relative to Poisson) Example 
more spaced 
more  
concentrated 
underdispersed 
variance < 
mean 
regular contamination 
due to contaminated 
filler head 
uniform random poisson 
variance = 
mean 
perfect mixing 
more clustered 
more right 
skewed 
overdispersed 
variance > 
mean 
local contamination 
from hand contact 
 
2.4.1 Frequency distributions modelling microorganisms in food 
Distributions used to model frequency distributions of microorganisms should 
satisfy five criteria if they are used to represent or approximate spatial distribu-
tions in real situations: 
i. The model outcome should not be negative; 
ii. The model should allow zero as an outcome; 
iii. The model outcome should be discrete numbers only; 
iv. The frequency distribution should reduce to, or at least approximate, the 
Poisson distribution; 
v. The frequency distribution should be similar to, or approximate, the 
Lognormal distribution at high numbers of microorganisms (when there 
is negligible probability of zero microorganisms). 
 
The reasons why distributions have to satisfy these criteria are easy to under-
stand. Indeed, it is not possible to have negative numbers of microorganisms in a 
food; it is possible to have no microorganisms in a portion of food; it is not possi-
ble to have parts of microorganisms in a portion as viable units. So the first three 
criteria can be satisfied considering frequency distribution will give zero probabil-
ity to negative values; gives a finite probability to zero values and should not as-
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sign probability to fractional numbers. For the last two criteria it can be shown 
that the Poisson distribution is the best distribution that models a uniform, ran-
dom, spatial distribution (obtained throughout a perfect mixing) and although 
the frequency distribution of microorganisms must be discrete when we are talk-
ing about very high values the difference between consecutive integers is so 
small to be approximated by continuous distributions and the Lognormal distri-
bution (described below) has been widely and successfully used to model micro-
organisms frequency distributions in many circumstances. 
 
Factual insight into the actual spatial distribution of microorganisms in 
foods is lacking and often generalizing assumptions are made that have become 
commonplace in day-to-day food safety management. Understanding spatial dis-
tributions of (harmful) microorganisms is vital for establishing proper microbio-
logical criteria and obtaining a realistic view of the performance of the associated 
sampling plans (Jongenburger, Bassett, Jackson, Zwietering, & Jewell, 2012). An 
assumption often used is that microorganisms are distributed lognormally, since 
this distribution appears to fit actual observations in foods (Kilsby & Baird-Parker, 
1983), or according to the Poisson distribution. However, while there is some 
mechanistic support for the use of these two statistical distributions, irregular 
clustering of microorganisms, for example, will impact on the frequency distribu-
tion and needs to be considered as well, so also another frequency distribution 
(Poisson-LogNormal) is analyzed. There are also other two frequency distribu-
tions sometimes used to model microorganism, the Gamma and the Negative Bi-
nomial, that are not described here. 
 
1. Poisson distribution (including generalized Poisson distributions) 
2. Lognormal distribution 
3. Poisson-Lognormal distribution (another type of generalized Poisson) 
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Poisson distribution (including generalized Poisson distributions) 
The Poisson distribution is a discrete probability distribution that expresses the 
probability of a given number of events occurring in a fixed interval of time 
and/or space if these events occur with a known average rate and independently 
of the time since the last event (Haight, 1967). 
The location is enough to define a single-parameter Poisson frequency dis-
tribution. Its dispersion as measured by variances, is equal to the mean. 
A Poisson frequency distribution models a uniform random spatial distribu-
tion, but it is also used in the absence of anything more appropriate (e.g., based 
on specific knowledge of the likely spatial distribution), even if a uniform random 
spatial distribution cannot be assumed. Problems concerning the use of Poisson 
distribution are related to the fact that this distribution is the correct choice for 
well-mixed products with low concentrations of microorganisms, but does not 
have the flexibility to model the variations in microbial concentrations seen in 
practice. Furthermore, when we consider high concentrations (e.g., above 20 
CFU (colony forming units)/portion) a Poisson distribution is essentially symmet-
rical, while observed distributions of microbial concentrations are often skewed 
to the right. For these reasons, generalized Poisson distributions are more flexi-
ble. 
The dispersion of a Poisson frequency distribution is measured by variance 
and it is equal to its mean; ‘over-dispersed’ distributions are the ones with vari-
ance less than the mean and reflect situations with clustering in the spatial dis-
tribution; ‘under-dispersed’ are the ones with variance greater than the mean, 
then reflects separation in the spatial distribution, that is situations more regular 
than a uniform random distribution (this kind of situation are however less 
common than over-dispersion in foods). 
Poisson frequency distributions are commonly used to assess microbiologi-
cal risk and to explain microbiological criteria. The degree of over- or under-
dispersion (clustering or spacing) of a particular distribution can be compared to 
a Poisson distribution, throughout the ratio between the variance and the mean: 
- ratio = 1 for uniform random spatial distributions, 
- ratio > 1 for clustered spatial distributions, and 
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- ratio < 1 for over-spaced distributions. 
 
A statistical test (Stoyan, 1994) for the presence of spatial clustering or 
over-spacing is based on the ‘dispersion index’, I: 
2
nsI
x
=  
where  
n = is the number of portion 
s2 = 
is the variance of points in each portion (with n-1) in the denom-
inator 
x  = is the mean number of points in each portion 
 
For a set of concentrations taken from a Poisson distribution (e.g. where 
the spatial distribution is uniform random) s2 is expected to be about equal to  
x , so I is about equal to n. In fact, for such a sample, I is distributed according to 
a
2χ  distribution with n-1 degrees of freedom and if n is greater than 6 and x  is 
greater than 1 then I can be tested against the 2χ  distribution (ILSI Europe, 
2010). If the cumulative 
2χ  probability is very small (e.g. less than 0.05) there is 
statistically significant evidence of over-spacing, and if it is very big (e.g. more 
than 0.95) there is statistically significant evidence of spatial clustering. 
 
Basing on the discussion above we can assume that the five criteria that 
distributions should satisfy to model frequency distributions of microorganisms 
are not all satisfied for the Poisson distribution: 
a. non-negative   YES 
b. allows zeros    YES 
c. discrete    YES 
d. approximates Poisson  YES 
e. approximates Lognormal  NO 
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One way to have more flexibility is using Generalized Poisson distributions 
than single-parameter Poisson distributions. In a generalized distribution a pa-
rameter of the simple distribution (the only parameter for a Poisson) itself fol-
lows a distribution. Expressed mathematically, a distribution containing a pa-
rameter θ , say ( )|f x θ , can be generalized by weighting it by a distribution for 
θ , say ( )p θ , and then integrating with respect to θ  to obtain the marginal dis-
tribution 
( ) ( ) ( )|g x f x p dθ θ θ+∞
−∞
= ∫  
For generalized Poisson distributions, the generalizing distribution, ( )p θ , 
describes the mean of the Poisson distribution, ( )|f x λ θ= , so that it is not lim-
ited to integer values, although it cannot be negative. 
So, a way to model clustering is to describe the number of clusters by a 
Poisson distribution and the number of points within each cluster by another dis-
tribution; this may also be viewed as a mixture of Poisson distributions with dif-
ferent means, where the means follow another distribution. The ‘generalized 
Poisson distribution’ models the total number of points in a given volume.  
The advantage of the generalized Poisson frequency distribution, in terms 
of the five proposed criteria, is the matter that preserve the advantages of the 
single-parameter Poisson, but not necessary having variance equal to its mean it 
can model the skewness associated with a Lognormal frequency distribution. 
 
a. non-negative     YES 
b. allows zeros   YES 
c. discrete    YES 
d. approximates Poisson  YES 
e. approximates Lognormal if the generalizing distribution is appropriate 
YES, otherwise NO. 
 
The ‘zero-inflated’ Poisson distribution is another kind of generalized Pois-
son distribution. This frequency distribution generates more zero values than a 
single parameter Poisson. As we can see in the example in Figure 2.4, this distri-
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bution has a fixed proportion of zero values (10% in the example), with the re-
mainder distributed according to a Poisson with a fixed mean, λ . Because the 
generalizing frequency distribution is discrete (i.e., Binomial or two valued; the 
mean of the Poisson is either 0 or λ ) the resultant generalized distribution can 
have more than one peak. 
 
Figure 2.4 - Zero-inflated Poisson frequency distribution, characterized with a Poisson distribu-
tion with an mean of 8 and with 10% of the values being zero 
 
This frequency distribution is useful in a particular situation, that is when 
the overall batch of food product can be considered to be a mixture of two dif-
ferent groups of portions, one with no contaminated portions, one contaminated 
in a uniform random pattern. The distribution, however, suffers, in terms of the 
five criteria, of the same problems of the single-parameter Poisson distributions. 
 
a. non-negative  YES 
b. allows zeros    YES 
c. discrete    YES 
d. approximates Poisson  YES 
e. approximates Lognormal  NO 
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Lognormal distributions 
A log-normal distribution is a continuous probability distribution of a random 
variable whose logarithm is normally distributed. Thus, if the random variable Y 
is log-normally distributed, then X = log(Y) has a normal distribution. Likewise, if 
X has a normal distribution, then Y = exp(X) has a log-normal distribution. A ran-
dom variable which is log-normally distributed takes only positive real values. It 
is defined by two parameters: the ‘location’ and the “scale” (values must be >0)
3
.  
As illustrated in Figure 2.5, when the logarithms of values follow a Normal 
distribution (top panel), the values follow a Lognormal distribution (bottom pan-
el). 
 
Figure 2.5 - Lognormal distribution 
 
                                                          
 
 
3
 Conventionally, parameters for the location and scale are the mean and standard deviation of 
the natural logs of the values. These can be converted to the log10 value which is more usually 
used in microbiology by dividing by ln(10) = 2.303. 
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There are several reasons that leads the Lognormal distribution to be of 
the most used distribution to model frequency distributions of microbial concen-
trations. First of all, microbiologists deal with numbers ranging from a few CFU to 
many billion and they are frequently represented by scientific notation (e.g., 1.23 
x 10
8
). So, working with decimal logarithms (e.g., 8.09) is more natural. Normal 
distributions are used very widely and successfully to represent distributions of 
values. The Normal distribution is well understood from a large number of peo-
ple. Furthermore the Lognormal distribution has a technical advantage: the Cen-
tral Limits Theorem says that (subject to some conditions) a value resulting from 
the sum of many independent effects will follow a Normal distribution. At last, 
the Lognormal distribution has some empirical justification, because it is 
nonnegative and reflects the tail to high values often associated with microbial 
concentrations.  
However, this frequency distribution present also some disadvantages. The 
most important is that it gives zero probability for zero concentration, so it does 
not allow complete absence of microorganisms. The second one is that it is con-
tinuous.  
Considering the five criteria, the Lognormal distribution presents the fol-
lowing characteristics: 
 
a. non-negative   YES 
b. allows zeros    NO 
c. discrete    NO 
d. approximates Poisson  NO 
e. approximates Lognormal YES 
 
Clearly, the first limitation is relevant and not negligible when the microor-
ganisms are present in food at very low levels while is almost negligible for very 
high concentrations (when we are talking of an average level of microorganisms 
of 1.000.000 CFU per portion, the difference between 1.000.000 and 1.000.001 
CFU is negligible and the probability of zero is not important). Therefore, the 
Lognormal distribution is not the right choice to model low numbers of microor-
ganisms; foodborne pathogens are usually present in very low concentrations. 
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Poisson-Lognormal distributions 
It is possible to model the mean of a discrete Poisson frequency distribution with 
the continuous Lognormal frequency distribution. The resulting frequency distri-
bution is a discrete Poisson-Lognormal distribution (Bulmer, 1974).   
The advantage of this frequency distribution is that complies with all five of 
the criteria proposed for suitability of a frequency distribution to model spatial 
distribution of microorganisms. Indeed the Poisson-Lognormal distribution is dis-
crete, non-negative and allows zeros. Furthermore it converges to the Poisson or 
to the Lognormal distribution.  
 
Figure 2.6 - Poisson-Lognormal distributions 
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a. non-negative  YES 
b. allows zeros   YES 
c. discrete   YES 
d. approximates Poisson YES 
e. approximates Lognormal YES 
 
The similarities between the distributions under different combinations of 
mean and over dispersion can be summarized as (Jongenburger, Bassett, 
Jackson, Zwietering, & Jewell, 2012):  
1. at high means, there is little difference between a continuous distribution 
and its discrete generalization of the Poisson distribution. While the dis-
crete distribution may be more theoretically correct, the continuous dis-
tribution is easier to use and gives practically the same results; 
2. at low means, the continuous statistical distributions can differ substan-
tially from their generalizations of the Poisson, and the generalized Pois-
son distributions should be preferred for low numbers of microorgan-
isms. 
 
We know that pathogens generally occurs at low levels in food and their dis-
tribution is almost always clustered. These peculiarities influence the choice of 
the frequency distribution; indeed, at high means and with little clustering, the 
choice of model statistical distribution has little effect; the simple Poisson is in-
appropriate in the presence of any substantial clustering; the continuous distri-
butions (Lognormal) is inappropriate when there is substantial probability of ze-
ros, especially at low means; the family of generalized Poisson distributions is 
appropriate under a wide range of circumstances. 
 
Beyond theoretical considerations, the choice of the distribution that bet-
ter describe the pathogens will depend on how effectively the different distribu-
tions fit to the real data. According to Kilsby & Baird-Parker and Gale, at high lev-
els of microorganisms, there is substantial positive experience supporting the use 
of the Lognormal distribution while at low levels of microorganisms, other distri-
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butions may be superior to relative to the Poisson distribution. Unfortunately 
there are little study about the use of the Poisson-Lognormal distribution. Some 
findings suggest the use of the Negative Binomial distribution. It has been found 
that this distribution fit microbial data characterized by a relatively high occur-
rence of zero counts better than the Poisson distribution (Gonzales-Barron, Kerr, 
Sheridan, & Butler, 2010)  
 
Among the ones described above, we can conclude that the Poisson-
Lognormal is the most suitable distribution with regard to the five proposed cri-
teria. The only biggest disadvantage of the Poisson-Lognormal is its mathemati-
cal complexity; the advantage is its capability to well-suit the distributions of mi-
crobial concentrations despite of the Lognormal that fail the suitability criteria 
that are important for being able to model low numbers of microorganism and 
the Poisson distribution that cannot model clustering.  
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3 – A case study: the ACME PIF production 
 
 
 
 
 
 
 
3.1 “Law sampling” and “Autosampling” in powered infant formulae 
A worldwide famous company, named “ACME” - we keep its name hidden for 
confidentially agreement with the management - produces powdered infant 
formula in two plants, one in England (ENACME) and one in Italy (ITACME). 
The company pursue a rigid strategy of control quality given the type of 
commercialized product and the possible consequences on the consumer of con-
taminated products. Commercialized contaminated product furthermore will 
have an effect on the prestige of the company and the image cost incurred. 
These actions of quality control are realized with the support of internationally 
recognized certification authorities. 
 
ACME, in controlling its quality production, operates different sampling 
plans in Italy or England. Both sites use “Autosampling” (where automatic mech-
anisms take many small aliquots throughout the production stream, which are 
combined into one larger aliquot for analysis) and “discrete sampling” (10 x 10g 
aliquots are taken and analyzed). Both sites examine and accept/reject product 
in quantities smaller than a complete batch ("sub-lot sampling") as well as in 
complete batches. We refer to these sampling plans as "ACME Sampling".  
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The International Commission on Microbiological Specifications for Foods 
(ICMSF) provided in 1974 urgently needed guidance on the use of sampling plans 
and the Microbiological Criteria (MC) for foods in international trade (ICMSF, 
1974). In particular, ICMSF proposed to use attribute sampling plans; these kind 
of plans consists of two types: a two-class plan used to classify the test samples 
as “acceptable” or “defective” and a three-class plan used to classify the test 
samples as “acceptable”,  “marginally acceptable” or “defective”. The microbio-
logical criteria define the acceptability of a product or a food lot, based on the 
absence or presence or number of microorganism and/or quantity of their tox-
ins/metabolites, per unit(s) of mass, volume, area or lot (Codex, 1997). 
 These sampling plans have been widely adopted by public and private par-
ties. They have been incorporated into specifications in commercial trading con-
tracts and have been enshrined in food law in different countries (Legan, 2001). 
Assessing the compliance of a batch to a MC depends on the criteria of the sam-
pling plans. In general, two-class sampling plans are used when the health hazard 
is severe and direct (ICMSF, 1974) (ICMSF, 2002) (Legan, 2001) and its plan strin-
gency depends on the number of samples tested (n) and the upper limit (m). 
Plans become more stringent as n increases and/or m decreases (Jongenburger, 
Reij, Boer, Gorris, & Zwietering, 2011). 
The powdered infant formula is subject to Commission Regulation (EC) No 
2073/2005 on microbiological criteria for foodstuffs (2005) which specifies "mi-
crobiological criteria defining the acceptability of the processes, and also food 
safety microbiological criteria setting a limit above which a foodstuff should be 
considered unacceptably contaminated with the microorganisms for which the 
criteria are set".  
 
Relevant criteria are the following two: 
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Food safety criteria 
Food category 
Micro-
organisms/their 
toxins,  
metabolites 
Sampling-
plan
(1)
 
Limits Analytical 
reference 
method
(2)
 
Stage 
where the 
criterion 
applies 
n c m M 
Dried infant formulae 
and dried dietary 
foods for special medi-
cal purposes intended 
for infants below six 
months of age 
Enterobacter  
Sakazakii (ES) 
30 0 
Absence 
in 10gr 
ISO/DTS 
22964 
Products 
placed on 
the market 
during their 
shelf-life 
(1)
 n = number of units comprising the sample; c = number of sample units giving values over m or be-
tween m and M. 
(2)
 The most recent edition of the standard shall be used. 
Interpretation of the test results 
Enterobacter Sakazakii in dried infant formulae and dried dietary foods for special medical 
purposes intended for infants below 6 months of age:  
— satisfactory, if all the values observed indicate the absence of the bacterium; 
— unsatisfactory, if the presence of the bacterium is detected in any of the sample units. 
 
Process hygiene criteria - Milk and dairy products 
 
Food category 
Micro-organisms/ 
their toxins,  
metabolites 
Sampling-
plan
(1)
 
Limits Analytical 
reference 
method
(2)
 
Stage where 
the criterion 
applies 
Action in case of  
unsatisfactory results 
 
 n c m M 
 Dried infant 
formulae and 
dried dietary 
foods for special 
medical purpos-
es intended for 
infants below six 
months of age 
Enterobacteriaceae 
(EB) 
30 0 
Absence 
in 10gr 
ISO 21528- 
1 
End of the 
manufacturing 
process 
Improvements in produc-
tion hygiene to minimize 
contamination. If Entero-
bacteriaceae are detect-
ed in any of the sample 
units, the batch has to be 
tested for E. Sakazakii 
and Salmonella 
 
(1)
 n = number of units comprising the sample; c = number of sample units giving values over m or between m and M. 
 
(2)
 The most recent edition of the standard shall be used. 
 Interpretation of the test results 
 Enterobacteriaceae in dried infant formulae and dried dietary foods for special medical purposes intended for infants 
below 6 months of age:  
 — satisfactory, if all the values observed indicate the absence of the bacterium; 
 — unsatisfactory, if the presence of the bacterium is detected in any of the sample units. 
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Also relevant is Codex Alimentarius Commission Code of hygienic practice 
for powdered formulae for infants and young children. CAC/RCP 66 - 2008. An-
nex I, Microbiological Criteria For Powdered Infant Formula, Formula For Special 
Medical Purposes And Human Milk Fortifiers. 
Two sets of criteria are provided below, one for pathogens and a second 
for process hygiene indicators. 
 
Criteria for pathogenic microorganisms 
These are to be applied to the finished product (powder form) after primary packaging or anytime 
thereafter up to the point when the primary package is opened. 
Microorganisms n c m Class Plan 
Enterobacter Sakazakii (Cronobacter species)* 30 0 0/10 g 2 
Where n = number of samples that must conform to the criteria: c = the maximum allowable 
number of defective sample units in a 2-class plan. m = a microbiological limit which, in a 2-class 
plan, separates good quality from defective quality. 
*The mean concentration detected is 1 CFU in 340g (if the assumed standard deviation is 0.8 and 
probability of detection is 95%) or 1 CFU in 100g (if the assumed standard deviation is 0.5 and 
probability of detection is 99%) 
 
Criteria for process hygiene 
These are to be applied to the finished product (powder form) or at any other previous point 
that provides the information necessary for the purpose of the verification. 
Microorganisms n c m M Class Plan 
 
Enterobacteriaceae** 10 2
(1)
 0/10 g Not applicable 2 
  
Where n = number of samples that must conform to the criteria: c = the maximum allowable 
number of defective sample units in a 2-class plan or marginally acceptable sample units in a 
3-class plan: m = a microbiological limit which, in a 2-class plan, separates good quality from 
defective quality 
        ** The mean concentration detected is 1 CFU in 16g (if the assumed standard deviation is 
0.8 and probability of detection is 95%) or 1 CFU in 10g (if the assumed standard deviation is 
0.5 and probability of detection is 99%). 
        
2
(1)
 This 2 class plan is proposed because a 3 class plan with equivalent performance would 
not be practical analytically, given the low levels of EB typically occurring when stringent hy-
giene conditions are maintained. 
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It may seem that peak contaminations in up to 2 samples are tolerated in this Microbiologi-
cal criterion (MC). However, it is assumed that the product is sufficiently homogeneous that 
high level contaminations will fail the MC. It is further assumed that, in practice, under suffi-
ciently strict hygienic operation, the manufacturer will normally not find positives and that if, 
occasionally, positives are found the manufacturer will take appropriate actions. 
        
Finding 1 or 2 positives should indicate to the manufacturer a trend toward potential loss of 
process control and appropriate actions would include further microbial evaluation of the 
implicated end product (i.e. re-evaluation of the EB content; when EB MC fails, evaluation of 
product safety using the proposed MCs for Salmonella and E. Sakazakii (Cronobacter species 
(Cronobacter species) before its release as well as evaluation of the hygiene programme to 
confirm it is suitable to maintain ongoing hygiene control or to amend the programme such 
that is suitable to do so). 
        Finding 3 or more positives should signal to the manufacturer loss of process control and 
appropriate actions should be the evaluation of product safety using the proposed MCs for 
Salmonella and E. Sakazakii (Cronobacter species) before release of the implicated product 
as well as evaluation of the hygiene programme to amend the programme such that it is 
suitable to maintain high hygiene control on an ongoing basis before production is resumed. 
 
Noting that CAC/RCP 66 - 2008 requires action on positive Enterobacteri-
aceae, even when only 1 or 2 positive aliquots are found in a sample of 10 ali-
quots, The EC and Codex criteria are consistent with each other and may be 
summarized as:  
a. Food safety criteria: Enterobacter Sakazakii: 30 x 10g aliquots, all negative  
b. Process hygiene criteria: Enterobacteriaceae: 10 x 10g aliquots, all negative  
 
 These sampling plans are the ones called "Law Sampling". Law Sampling 
does not explicitly specify random aliquots, but EC 2073/2005 defines ‘repre-
sentative sample’ as "a sample in which the characteristics of the batch from 
which it is drawn are maintained. This is in particular the case of a simple random 
sample where each of the items or increments of the batch has been given the 
same probability of entering the sample". In practice, it seems likely that Law 
Sampling will be intended to be random. 
 Apart from the technical aspects, it is important to remark that all the 
companies producing powdered infant formula have to comply with these legal 
requirements.  
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Recently, “ACME” management decided to assess possible differences in 
effectiveness between Law Sampling and “ACME” Sampling. In particular ACME 
wishes to asses if its sampling procedure a better (and how much better) than 
the Law one in detecting contaminated batches. The organization that usually 
supports the company in quality control released a technical report containing a 
lot of mathematical and statistical analysis very hard to understand from the 
management. For this reason the management asked two Ph.D students, one in 
math and one in applied statistics, to check the content of the report and verify 
the accuracy and the clarity of their statements. 
ACME released internal production and sampling data with the agreement 
that the data can be used only for scientific purpose without mentioning the 
company directly. 
3.2 ACME requests 
Three specific questions were addressed from ACME management to the quality 
control organization and therefore to the two Ph.D students:  
1) Is ACME Sampling better than Law Sampling?  
Is the ACME Sampling, especially Autosampling, demonstrably more like-
ly to detect contamination than Law Sampling (10 g aliquots taken ran-
domly)?  
2) How much better?  
If ACME Sampling is demonstrably better than Law Sampling, can the 
difference be quantified?  
3) What is the residual risk of in-market positive Law Sampling?  
No sampling scheme is perfectly effective in detecting contamination, so 
there is always the possibility that a contaminated batch will be 'missed' 
on one occasion to be detected later. What is the residual risk that a lot 
released following ACME Sampling will be found positive if later exam-
ined by Law Sampling? This should consider that later Law Sampling 
might be applied to a complete batch, or to an approximately contigu-
ous part of a full batch.  
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3.3 Available data from the production process 
In this work we try to answer to the questions addressed by the management us-
ing only data coming from the Italian plant.  
Generally, ITACME produces two batches of powder in a day. The dimen-
sion of a batch varies between 3.600 and 17.000 cans of milk powder depending 
on the size of the cans (3.600-12.000 for the 800 gram cans and 6.000-17.000 for 
the 350 gram cans). As soon as the cans come out of the processing pipeline they 
are placed in pallets containing 200 of the larger cans (160 Kg) or 252 (88 Kg) of 
the smaller ones. In one hour either 7 pallets containing 1.400 big cans or 10 pal-
lets containing 2.520 small cans are produced. This means 23.3 large cans or 42 
small cans every minute. 
 
Figure 3.1 - Flow diagram of ITACME sampling plan 
 
 
 
In the Figure 3.1 above is described “ACME” sampling plan of the Italian plant: 10 
cans are randomly selected from the produced batch, 10 g from each can is se-
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lected, and the mixed 100g are tested for EB. 10g every 2 minutes are collected 
during the process (autosample), the collected powder is mixed and 300g are 
tested for ES: 
- if both tests are negative, the batch is released for marketing; 
- if test for ES is positive, the batch is not OK and will go to the sub-lot 
analysis; 
- if test for ES is negative and for EB is positive, from the autosample col-
lected powder 750g are retested for ES; 
- if the 750g retesting is negative the batch is released, if positive the batch 
will go to the sub-lot analysis.  
 
Figure 3.2 - Sub-lot analysis per pallet flow diagram 
 
 
 
For the sub-lot analysis (Figure 3.2), for each pallet, a case is chosen from 
the top of the pallet: the powder of all the cans is mixed and 300 g are tested for 
ES. Pallets are made up of: 
a) 50 cases = 160Kg – 4 x 800g cans per case  
b) 60 cases = 192 Kg – 4 x 800g cans per case  
c) 42 cases = 88.2 Kg – 6 x 350g cans per case  
d) 42 cases = 100.8 Kg – 6 x 400g cans per case  
that take, at the maximum processing speed, respectively, 3’’20’’, 4’, 3’9’’and 
2’45’’ to be produced. If the test for ES is negative the pallet is released, if posi-
tive the pallet is discarded. 
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The available data concern all the test performed by ACME from 2006 to 
2011. Data on 1864 batches are organized per year of production, batch identifi-
cation number, product types (“stage”: before 6 months; 6 to 12 months; later), 
type of packaging, and results of the EB and ES tests. 
 
Table 3.1 - Number of batches, by year and stage  
(Bag-in-Box and Can only) 
 
First Follow up Growth 
 
2006 90 106 0 196 
2007 157 130 0 287 
2008 176 135 0 311 
2009 164 107 0 271 
2010 148 94 0 242 
2011 73 56 13 142 
Total 808 628 13 1449 
 
Table 3.2 - Number of batches, by year and type of packaging 
(Bag-in-Box and Can only) 
 
Bag in box Can 
 
2006 196 0 196 
2007 287 0 287 
2008 311 0 311 
2009 36 235 271 
2010 0 242 242 
2011 0 142 142 
Total 830 619 1449 
 
Table 3.3 - Number of batches, by year and stage  
(Free sample and free sample bag only) 
  First Follow up Growth   
2006 5 40 0 45 
2007 22 78 0 100 
2008 14 58 0 72 
2009 31 52 0 83 
2010 37 22 0 59 
2011 22 32 2 56 
Total 131 282 2 415 
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Table 3.4 - Number of batches, by year and type of packaging 
(Free sample and free sample bag only) 
 
Free sample 
bag 
Free sample 
bag in box  
2006 40 5 45 
2007 82 18 100 
2008 67 5 72 
2009 82 1 83 
2010 59 0 59 
2011 56 0 56 
Total 386 29 415 
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4 – THE CURRENT APPROACH FOR THE DETECTION OF ES IN THE PIF  
PRODUCTION 
 
 
 
 
 
 
 
4.1 Theoretical background  
The distributions of how microorganisms are physically distributed in foods de-
termine both the likelihood that a foodstuff will cause illness and the consequen-
tial public health burden, but there is relative little knowledge about these, yet. 
The spatial distribution of the microorganisms in foods determines the value of 
the data on prevalence and/or concentration, obtained through sampling and 
testing, for informing food safety management decision-making (e.g., for lot ac-
ceptance or for process control) and, ultimately, their value for determining the 
associated public health burden (ILSI Europe, 2010).  
Ideally, a batch of food should be produced under uniform and constant 
conditions; this means that the microorganisms present in the batch should be 
homogeneously distributed. Under this hypothesis (when drawn from a perfectly 
homogenously contaminated batch), the level of microorganisms present in an 
aliquot of a random samples would be distributed according to the Poisson dis-
tribution and would depend only on the microbial concentration within the batch 
(Jongenburger, Reij, Boer, Gorris, & Zwietering, 2011).  
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In practice, however, as we saw in the previous chapter, microorganisms 
are rarely homogeneously distributed within batches of food. Due, for instance, 
to the heterogeneity of the food matrix, incidental contamination, localized mi-
crobial growth or incomplete mixing, microorganisms are heterogeneously dis-
tributed, which results in an unequal probability to detect microorganisms in 
equal amounts of powder drawn throughout different parts of the whole batch. 
Depending on when and how the contamination has occurred during the produc-
tion or thereafter, the spatial microbial distribution within the batch may also 
vary in size and concentration (Jongenburger, Reij, Boer, Gorris, & Zwietering, 
2011).  
Generally, sampling strategies are based on these assumptions. It has been 
shown that logarithms of counts from a batch of food are likely to be normally 
distributed (Kilsby & Baird-Parker, 1983); total viable counts data from batches of 
frozen meat, frozen vegetable, frozen dairy, and powdered products appeared to 
be lognormally distributed in 92% of the batches; in 8% of the batches, the total 
viable count appeared to be not lognormally, with a maximum of 13% for pow-
dered products (Kilsby & Baird-Parker, 1983). Based on studies such as that of 
Kilsby and Baird-Parker, the International Commission Microbiological Specifica-
tion for Foods assumed a lognormal distribution in order to evaluate the perfor-
mance of attribute sampling plans (ICMSF, 2002). 
In dried milk product it has been established that clustering and heteroge-
neity occurs and that there is a substantial stratification of contamination 
(Habraken, 1986). If the contamination is homogenously distributed, the proba-
bility to detect it by definition would be the same for each sample, no matter 
what sampling scheme is used. However, if the contamination is heterogeneous-
ly distributed or clustered in local spots, the sampling strategy becomes im-
portant (Jongenburger, Reij, Boer, Gorris, & Zwietering, 2011).  
The literature on the subject reports a series of statements, mostly not 
proven, that we are mentioning only for completeness but on whose truth we 
have some doubts. We will get back to it at the end of this chapter. 
Theoretical considerations suggest that sampling plans incorporating Au-
tosampling should be better at detecting clustered contamination than a plan 
59 
analyzing the same amount of material taken as random (Jongenburger, Reij, 
Boer, Gorris, & Zwietering, 2011).  
Systematic sampling was reported to be more effective in detecting  a lo-
calized contamination (Habraken, 1986). Since systematic sampling improves the 
probability of detection, this improvement depends on the contaminated frac-
tion and the number of aliquots taken. The improvement reaches a maximum, 
when exactly one systematic aliquot will be drawn from the contaminated frac-
tion. In this case, the sampling interval equals the size of the contaminated frac-
tion. Estimating the size of the contaminated fraction or the optimal sampling in-
terval is a ‘chicken and egg’ dilemma. However, if one can estimate the size of 
the contaminated fraction, the optimal number of systematic samples may be 
derived from that (Jongenburger, Reij, Boer, Gorris, & Zwietering, 2011). This is 
surely valid when there is a single localized contaminated fraction. But what does 
it happen when there are multiple localized contaminated fractions in a batch? 
Jongenburger et. al. showed in a further studio that stratified random sam-
pling improved the probability to detect the heterogeneous contamination when 
there is systematic contaminations (caused, for example, by a contaminated filler 
head). Taking more and smaller samples and keeping the total sampling weight 
constant, clearly improved the performance of the sampling plans. Therefore to 
improve the probability of detection, Autosampling employed just before filling 
will be a practical way to collect the necessary large number of small samples per 
batch (Jongenburger, Reij, Boer, Gorris, & Zwietering, Actual distribution of 
Cronobacter spp. in industrial batches of powdered infant formula and 
consequences for performance of sampling strategies, 2011). 
Again, we do not fully agree with most of the statements made above but  
we are not yet ready to refute them (more later). 
4.2 Executive report from the control quality organization 
The full report produced by the control quality organization has not been re-
leased by the ACME management. An executive report is the only document that 
has been granted for consultation. This document summarizes the answers given 
to ACME by the control quality organization. 
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1) Is ACME Sampling better than Law Sampling?  
Basing on the fact that all batches contain at least one Enterobacteriaceae 
bacterium, so a perfectly sensitive plan would detect bacteria in practically 
every batch, the effectiveness of a sampling procedure depends, inter alia, on 
the total amount of material tested. ACME sampling procedures analyze more 
material than Law sampling so, all other things being equal, ACME procedures 
would be more likely to detect contamination than Law sampling.  
Furthermore, being the contamination clustered, systematic sampling is 
more likely to detect contamination that random sampling (Habraken, 1986). 
For these two reasons ACME sampling will detect contamination more likely 
than Law Sampling. 
 
 
2) How much better?  
There are several variants of ACME sampling, and different changing circum-
stances, so any single answer is simplistic. At high contamination levels (over 
about 30 CFU/kg) all sample sizes are very likely to detect contamination, they 
are effectively equivalent. At very low levels (less than about 1 CFU/kg) the 
probability of detection is approximately proportional to the sample size - 
doubling the sample size doubles the probability of detection.  
The different clustering patterns have only small effects on detection 
probabilities in the contamination ranges of interest; so the differences be-
tween systematic and random sampling are small. 
In conclusion, at the low contamination levels seen in 2011 ACME sam-
pling is more likely than Law Sampling to detect contamination by a factor of 
very approximately 2 times; it seems that this is attributable more to total 
sample size than to systematic sampling. The increases in the higher probabil-
ity of detecting higher levels of contamination are more limited. Clustering 
causes only small reductions in detection probability for random (Law) sam-
pling; those small reductions are almost completely compensated for by struc-
tured (ACME) sampling.  
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3) What is the residual risk of in-market positive Law Sampling?  
Considering that only small differences are caused by clustered/uniform distri-
butions and by random/systematic sampling, calculations to answer to this 
question are on the basis of uniform distribution and random sampling. 
Considering all batches of released product to be equally contaminated at 
levels indicated by the effective overall concentrations (0,28 CFU/kg), the de-
tection probability for a 300gr sample is 8,14%. However, clustering has little 
effect if aliquots are taken at random from the whole batch: if all 30 aliquots 
in a sample come from a single random clustered stratum, the probability is 
somewhat reduced. If we assume that all released batches have been tested 
for EB and found negative (this is not strictly true - sometimes EB positive por-
tions of batches are removed and the remainder released), we know that ES 
detection probabilities may be one-half to one-quarter of that in all batches, 
so the probability still decrease. Considering, finally, that the contamination 
levels in 2011 are substantially lower than earlier years, we conclude that the 
residual risk of in-market positive law sampling in 2011 is estimated to be in 
the range 0.25% to 8,14%, probably in the lower half of that range. 
4.3 Random versus systematic sampling 
To understand the reasons that led the control quality organization to produce 
those answers we firstly try to reconstruct their computations on the basis of the 
results published on the executive report and the data provided by ACME. 
For any sampling plan, the probability of detection depends on the number 
of bacteria (CFU), being zero when there are no CFU (it is in general assumed 
that the analysis gives no false positives) and approaching 100% when the num-
ber of CFU is very large. To assess a sampling plan it is fundamental to have some 
idea of the typical contamination level; should we consider small numbers of CFU 
per batch (0, 1, 2, …), or millions, or somewhere in between? 
The effect of a sampling scheme also depends on the distribution of con-
tamination levels between batches. At one extreme, if all the batches are equally 
contaminated, there are no "good" and "bad" batches; the sampling plan has an 
equal chance of detecting contamination in all batches; the plan identifies batch-
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es as good or bad at random. At the other extreme, if most of the batches have 
very low or very high contamination and only few batches have intermediate 
contamination, it is much easier for the sampling plan to distinguish batches.  
To assess and compare sampling plans we need to make judgments on the 
between-batch distribution of contamination levels, as well as the range and typ-
ical contamination levels. 
The principal influence on the probability of a given sampling plan detect-
ing contamination is the number of bacteria in the batch, but this probability is 
also influenced by the arrangement of the bacteria in the batch. If the bacteria 
are randomly spread so that they are equally likely in all regions of the batch (the 
concentration is uniform throughout the batch) then it doesn't matter where the 
material in the sample is taken from. If the bacteria are concentrated in one (or a 
few) regions of the batch then a random sample may miss those regions. A sam-
ple made up of systematically taken aliquots may have a higher probability of de-
tection, depending on the sampling plan and the pattern of contamination in the 
batch.  
To assess and compare sampling plans we need to estimate within-batch 
distributions of contamination levels. 
 
In the first two answers, the control quality organization focuses more on 
the amount of powder selected for testing that on the sampling schemes adopt-
ed. Acme sampling tests more product (300gr + 750gr if enterobacteriaceae tests 
positive) than Law testing, however the two sampling schemes can be compared 
taking into account the same amount of powder (i.e. excluding from the analysis 
the results of the retesting procedures). 
Furthermore, while in the first answer they state (quoting the work of Ha-
braken, 1986) that Autosampling is better than Law sampling in detecting con-
taminated batches (because “systematic sampling is more likely to detect con-
tamination that random sampling”), in the second one they state that “the dif-
ferent clustering patterns have only small effects on detection probabilities in the 
contamination ranges of interest; so the differences between systematic and 
random sampling are small”.  
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Do we have data to prove that? If we would have data on Auto and Law 
tests done on the same batches and assuming that if test is positive the batch is 
contaminated, the sampling schema that have a greater percentage of positive 
test is better. 
Among the available data, we have 41 batches that were tested with both 
testing procedures; in 2006 a number of randomly selected batches were sam-
pled and tested for ES by both 300g composite autosample and 30x10g random 
sampling. Results are shown in Table 4.1:  
 
Table 4.1 – Numbers of positive batches by Auto/Law sampling 
    30 x 10g Law sample   
    negative positive total 
Autosample 
negative 33 0 33 
positive 5 3 8 
 
total 38 3 41 
 
The proportion of positives from Autosampling (8 / 41 = 19.5%) is signifi-
cantly greater than the proportion from Law-sampling (3 / 41 = 7.3%) (one-sided 
exact Liddell test (Liddell, 1983), p = 0.031). The observed difference is 19.5% - 
7.3% = 12.2% or expressed as a ratio 19.5% / 7.3% = 2.67. The lower 95% confi-
dence limit on the ratio is 1.09.  
Nevertheless, we have to observe that 41 batches are quite few, that the 
confidence intervals for the difference are unfortunately very wide due to the 
small size of the sample and the percentage of contaminated batches is too high 
(considering the available data concerning all the test performed by ACME from 
2006 to 2011 as we will see the following analysis). For these reasons, we have 
some doubt about the drawing at random of these 41 because they do not seem 
a sample of the entire population of produced batches. 
 
Despite of our above findings, in our opinion the two answers of the con-
trol quality control are quite incongruent: a sampling strategy cannot be consid-
ered a priori better than another. As a matter of fact, it is possible to demon-
strate that the effectiveness of a sampling strategy is strongly affected by the 
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spatial distribution of the CFU inside the batch (in terms of typology and num-
bers of clusters).  
Let N be the total number of aliquots in a batch and suppose we stratify 
the N aliquots in K strata. Each stratum has  
 =  aliquots. Let’s denote the ali-
quots in stratum  ( = 1, … , ) , , … , . Assume that r of the aliquots in 
the batch are contaminated and that  < . If we draw randomly n aliquots 
from the entire batch, the probability of drawing at least one contaminated ali-
quot is approximately  
(+) = 1 −  =1 − (1 − ) 
if we assume that N is sufficiently large (i.e. using the binomial rather than the 
hypergeometric distribution) and   =  (i.e. the probability of drawing a con-
taminated aliquot in a single draw). 
If sampling is systematic and  = , and assume extreme clustering (all r 
contaminated aliquots are concentrated in one stratum), the probability of test-
ing positive (i.e. the probability of exactly one contaminated aliquot) is 
+ ! =  = " =
 ∙ " =  ∙    
where  + = positive testing with systematic concentrated. So, it could be 
demonstrated that 
+ ! ≥ (+)       
If the r contaminated aliquots are in different strata the probability is the 
same if the intervals of contaminated aliquots are disjoint. If there is some over-
lapping of the contaminated intervals in different strata, the (+) will decrease 
and the decrement depends on the amount of overlapping, reaching the mini-
mum if every stratum has exactly the same contamination interval (perfect over-
lapping). The (+) in this case  
 +%& = + ! =
 ∙ " = " =  ∙  =  '  
 
65 
One suggestion (Jongenburger, Reij, Boer, Gorris, & Zwietering, 2011) could 
be to draw randomly from each stratum a certain number of aliquots. Following 
this suggestion and assuming that the number of aliquots drawn in each stratum 
is the same, if  = , we should draw one aliquot from each stratum. Consider 
now a sample space ( = ), , … ,  * where the +  (, = 1, … , ) are the ali-
quots in a generic stratum. Denote by (  the subset of contaminated aliquots in 
stratum i. (  can be considered a subset of A and hence an event of the sample 
space A. If we draw one aliquot from (  
(() = - (- = ./0 12 -13304 56.137) 
Hence,  
+89:! = 1 − ; ((<= ) => 1 − ;1 − (()!

>  +8! reaches the minimum if ∏ ((<= )>  is maximum.  
 
Since ∑ (() => ∑ AB = ∑ AB>  = constant 
the distribution of the ci among the strata is irrelevant. It is easy to show that the 
maximum of ∏ ((<= )>  is reached if ((<= ) is the same for each i (i.e. the num-
ber of contaminated aliquots is the same in each stratum). In this case 
+89:! = 1 − ; ((<= ) => 1 − ; C
 −  D =

>  
1 − ; 1 −  ∙  = 1 − 1 −  ∙ 

>  
At the other extreme, if all  contaminated aliquots are in one stratum 
(concentrated), then 
 +89:  = 1 − ; ((<= ) =

> 1 − 
 −  ∙ 1 ∙ … ∙ 1 = 1 − 1 +  =  
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Table 4.2 summarizes, for certain numbers of contaminated aliquots, the 
probability values relating to the sampling strategies illustrated above, for an 
ideal batch of 4,5 tons (450,000 10g aliquots) and a sample of 30 aliquots. 
 
Table 4.2 – Detection probabilities of different sampling strategy for certain number of 
contaminate aliquots (in a batch of 4,5 tons and a sample of 30 aliquots) 
Cont.  
aliquots 
E(+F) E+GH! E +GIJ E+FG! E +FGKFH  
300 0.0198 0.0200 0.0007 0.0198 0.0200 
500 0.0328 0.0333 0.0011 0.0328 0.0333 
800 0.0520 0.0533 0.0018 0.0520 0.0533 
1500 0.0953 0.1000 0.0033 0.0953 0.1000 
2000 0.1251 0.1333 0.0044 0.1251 0.1333 
3000 0.1818 0.2000 0.0067 0.1818 0.2000 
5000 0.2848 0.3333 0.0111 0.2848 0.3333 
10000 0.4904 0.6667 0.0222 0.4904 0.6667 
15000 0.6383 1.0000 0.0333 0.6383 1.0000 
 
 
In the third answer “considering that only small differences are caused by 
clustered/uniform distributions and by random/systematic sampling, calculations 
to answer to this question are on the basis of uniform distribution and random 
sampling” the control quality organization assumes that all the batches are that 
all the batches are identical and that the aliquots follow a uniform distribution. 
As said above, if all the batches are identical and hence equally contami-
nated, there are no "good" and "bad" batches; the sampling plan has an equal 
chance of detecting contamination in all batches; the plan identifies batches as 
good or bad at random. Furthermore, if the aliquots follow a uniform distribution 
the residual risk of in-market positive Law Sampling will be exactly the same as 
the one found in the original batches. Notice, however, that detection of con-
tamination is independent of the sampling plan and hence the assumption of 
random sampling is irrelevant. In this case, assuming a Poisson distribution, the 
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mean concentration level can be easily computed by the probability of detecting 
a contaminated batch.  
In fact, let’s assume that we draw randomly from a batch an aliquot and 
analyze the aliquot to find how many CFU it contains. Let’s denote by X the num-
ber of CFU found and define negative (-ve) test if X = 0, positive (+ve) test if X ≠ 0: 
(−L0 3073) = (M = 0) = 1 −  (+L0 3073) = (M > 0) =  
 Let’s suppose that we draw n aliquots from the batch and assume that the 
number of aliquots in the batch is large enough to be assumed infinite and ana-
lyze individually the n aliquots.  
Let’s denote by Z the number of aliquots that test positive; if sampling is 
random, P ~ R(, ) no matter what the distribution of X is, and p is the proba-
bility that an aliquot drawn randomly from the batch tests positive. 
Let’s go now the other way around i.e. let’s suppose we randomly draw n 
aliquots from each batch of a certain number of batches. This will produce an 
empirical distribution of values from 0 to n each with frequency fi (i = 0 ,…, n). If p 
is constant across batches then the empirical distribution is a sample from P ~ R(, ) and we can also test the empirical distribution described above 
against P ~ R(, ). Rejection of the binomial would imply that our assumptions 
are wrong, i.e. p varies across batches.  
If X is a P(λ) for all the batches analyzed and λ is constant across batches,  
(M = 0) = 0U = 1 −  
where 
 = 1 − (M = 0) = 1 − 0U 
is the probability that the single aliquot tests positive. If you draw n ali-
quots 
(+L0 /3-ℎ) = 1 − (P = 0) = 1 − (1 − ) = 1 − W(M = 0)X 
and the probability that the test is positive will depend on the number of aliquots 
drawn (tends to 1 for n that goes to infinity). 
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Hence if we know p we can get λ 
 = 1 − (M = 0) ⇒ (M = 0) = 1 −  = 0U 
and 
Z = −51[(1 − ) 
Furthermore 
 = 1 − 1 − (+L0 /3-ℎ)! 
and p could be estimated from the results of the batch testing. 
If sampling is random and we assume that P(X > 0) is constant across 
batches, it is generally possible to go from the distribution of Z to the distribution 
of X if X is a one parameter distribution, while this is not possible if X is a two or 
more parameter distribution. 
If the drawing of aliquots is systematic (Autosampling, for example) Z will 
be a Binomial if the distribution of CFU is a Poisson (i.e. a random spatial distri-
bution). If the spatial distribution is not random (in particular if there is cluster-
ing) and the sampling is systematic the distribution of Z will still assume values 0, 
1, …, n but it will not be a binomial even if p is constant across batches. Hence, if 
the drawing is systematic, we should test the empirical distribution against the 
binomial (, ̂), and if the test rejects the binomial we should conclude that the 
frequency distribution of CFU is not a Poisson or that p is not constant across 
batches. Presumably, even assuming constant p across batches, farther away is 
the empirical distribution from the binomial the more clustering there is. How to 
measure the distance between the empirical distribution and the R(, ) is mat-
ter of academic research (value of ] or likelihood ratio statistic? Distance be-
tween empirical variance and (1 − )?). 
 
Let us go back to the data provided by ACME. Assuming that the distribu-
tion of CFU in the batch follows a uniform distribution and considering only the 
results of the auto-test without the retesting, we get the following results: 
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Table 4.3 - Number of ES positive batches, by year 
(Bag-in-Box and Can only – 300g testing) 
 
Negative Positive % of +ve Total 
2006 185 11 5,6% 196 
2007 276 11 3,8% 287 
2008 273 38 12,2% 311 
2009 231 40 14,8% 271 
2010 224 18 7,4% 242 
2011 142 0 0,0% 142 
Total 1331 118 8,14% 1449 
 
Table 4.4 - Number of EB positive batches, by year 
(Bag-in-Box and Can only – 100g testing) 
 
Negative Positive % of +ve Total 
2006 169 27 13,8% 196 
2007 262 25 8,7% 287 
2008 246 65 20,9% 311 
2009 221 50 18,5% 271 
2010 206 36 14,9% 242 
2011 131 11 7,7% 142 
Total 1235 214 14,8% 1449 
 
Table 4.5 - Probabilities of positive samples and "effective" overall concentrations 
  95% confidence interval 
 
Estimation Lower limit Upper limit 
ES (30 x 10g) 
Pr(+) 8,14% 6,73% 9,55% 
CFU/kg
4
 0,28 0,23 0,33 
EB (10 x 10g) 
Pr(+) 14,80% 12,97% 16,63% 
CFU/kg 1,6 1,39 1,82 
 
The level of contamination ('CFU/kg') of ES that would give the observed 
proportion of positive 300 g aliquots under the mentioned assumptions, would 
be 0.28 CFU/kg, 1.6 CFU/kg for EB, as stated in the executive report. 
                                                          
 
 
4
 The concentration of CFU was calculated assuming a Poisson distribution 
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The CFU/kg levels above indicate the order of magnitude of 'typical' con-
tamination levels; that overall contamination levels - averaged across many 
batches - are in tenths of CFU/kg for ES and several CFU/kg for EB.  
Through the ordinary tests of association it is possible to demonstrate that 
the batches analyzed are not identical and hence p is not constant across batch-
es. Different groups of batches are contaminated differently and there is strong 
evidence that the concentration of ES and EB, and the probability of a positive 
aliquot and/or sample, varies between batches. Furthermore, we will show that 
concentration of CFU varies also within batches. So that there is no single con-
centration and probability applicable to a single batch or a group of batches. 
These contamination levels must hence be treated with caution. 
 
The percentage of batches positive for EB (Table 4.6) is on average equal to 
14.8%, but quite variable in the different years: very high in 2008 and 2009 
(20.9% and 18.5%, respectively) and remarkably low in 2011. Statistically we can 
conclude that this percentage is certainly different in different years (p-value < 
0.001), even if the index of association Cramer’s V is not very high (13.5%).  
Even more pronounced is the difference in the percentages of batches pos-
itive for ES for the different years (Table 4.7): from a high 16.6% for 2009 to 0% 
in 2011. The conclusion is that the yearly ES percentages, like EB, change from 
year to year but, from the available data, we cannot show any overall time trend. 
The association index is higher than that for EB but not remarkably high (18.4%). 
The association between results on EB tests and months (Table 4.8) is bare-
ly significant (p≈0.02), but the strength of the association is quite weak (Cramer’s 
V = 12.3%) and the only month for which we notice a clear difference is April.  
More pronounced is the association month-positive ES test (Table 4.9)  
(p-value < 0.0001). As expected, the summer months, particularly August, have a 
much higher percentage of positive (22.2%).  
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Table 4.8 - Number of EB positive batches, by year 
(Bag-in-Box and Can only) 
 
Negative Positive % of +ve Total 
2006 169 27 13,8% 196 
2007 262 25 8,7% 287 
2008 246 65 20,9% 311 
2009 221 50 18,5% 271 
2010 206 36 14,9% 242 
2011 131 11 7,7% 142 
Total 1235 214 14,8% 1449 
 
Association statistics Symmetric Measures 
  Value df Asymp. Sig.   Value Approx. Sig. 
Pearson Chi-Square 26,293 5 < 0,001 Cramer's V 0,135 < 0,001 
Likelihood Ratio 27,439 5 < 0,001 N of Valid Cases 1449 
  
 
 
Table 4.7 - Number of ES positive batches, by year 
(Bag-in-Box and Can only) 
 
Negative Positive % of +ve Total 
2006 182 14 7,1% 196 
2007 275 12 4,2% 287 
2008 271 40 12,9% 311 
2009 226 45 16,6% 271 
2010 224 18 7,4% 242 
2011 142 0 0,0% 142 
Total 1320 129 8,9% 1449 
 
Association statistics Symmetric Measures 
  Value df Asymp. Sig.   Value Approx. Sig. 
Pearson Chi-Square 48,99 5 < 0,001 Cramer's V 0,184 < 0,001 
Likelihood Ratio 59,129 5 < 0,001 N of Valid Cases 1449 
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Table 4.8 - Number of EB positive batches, by month 
(Bag-in-Box and Can only) 
  Negative Positive % of +ve Total 
January 57 14 19,7% 71 
February 111 14 11,2% 125 
March 82 18 18,0% 100 
April 97 6 5,8% 103 
May 95 19 16,7% 114 
June 125 35 21,9% 160 
July 118 25 17,5% 143 
August 37 8 17,8% 45 
September 149 22 12,9% 171 
October 140 17 10,8% 157 
November 136 18 11,7% 154 
December 88 18 17,0% 106 
Total 1235 214 14,8% 1449 
 
Association statistics Symmetric Measures 
  Value df Asymp. Sig.   Value Approx. Sig. 
Pearson Chi-Square 21,928 11 0,025 Cramer's V 0,123 0,025 
Likelihood Ratio 23,013 11 0,018 N of Valid Cases 1449 
  
Table 4.9 - Number of ES positive batches, by month 
(Bag-in-Box and Can only) 
 
Negative Positive % of +ve Total 
January 62 9 12,7% 71 
February 118 7 5,6% 125 
March 93 7 7,0% 100 
April 100 3 2,9% 103 
May 101 13 11,4% 114 
June 132 28 17,5% 160 
July 122 21 14,7% 143 
August 35 10 22,2% 45 
September 160 11 6,4% 171 
October 145 12 7,6% 157 
November 150 4 2,6% 154 
December 102 4 3,8% 106 
Total 1320 129 8,9% 1449 
 
Association statistics Symmetric Measures 
  Value df Asymp. Sig.   Value 
Approx. 
Sig. 
Pearson Chi-Square 51,713 11 < 0,0001 Cramer's V 0,189 < 0,001 
Likelihood Ratio 50,543 11 < 0,0001 N of Valid Cases 1449 
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Analyzing the data of the plant it is clear that the quality of the process in 
terms of contamination was strikingly improved in recent times. It was hence de-
cided to report some of the descriptive statistics using only the more recent da-
ta. It was felt that 18 months was an adequate length of time to consider the 
process stable on the new level of contamination. 
If we consider only the last 18 months, positive tests for EB and ES (Table 
4.10 and 4.11) are not statistically associated with months. This is perhaps due to 
the much smaller sample size and the extremely small number of positives, par-
ticularly for ES. 
 
Table 4.9 - Number of EB positive batches, by month 
(Bag-in-Box and Can only) 
(from may 2010 - latest 18 months) 
 
Negative Positive % of +ve Total 
January 10 1 9,1% 11 
February 14 1 6,7% 15 
March 10 0 0,0% 10 
April 22 1 4,3% 23 
May 23 5 17,9% 28 
June 39 6 13,3% 45 
July 29 1 3,3% 30 
August 4 1 20,0% 5 
September 43 7 14,0% 50 
October 41 4 8,9% 45 
November 22 3 12,0% 25 
December 21 0 0,0% 21 
Total 278 30 9,7% 308 
 
Association statistics Symmetric Measures 
  Value df Asymp. Sig.   Value Approx. Sig. 
Pearson Chi-Square 10,245 11 0,508 Cramer's V 0,182 0,508 
Likelihood Ratio 13,207 11 0,280 N of Valid Cases 308 
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Table 4.10 - Number of ES positive batches, by month 
(Bag-in-Box and Can only) 
(from may 2010 - latest 18 months) 
 
Negative Positive % of +ve Total 
January 11 0 0,0% 11 
February 15 0 0,0% 15 
March 10 0 0,0% 10 
April 23 0 0,0% 23 
May 27 1 3,6% 28 
June 45 0 0,0% 45 
July 30 0 0,0% 30 
August 5 0 0,0% 5 
September 49 1 2,0% 50 
October 40 5 11,1% 45 
November 25 0 0,0% 25 
December 21 0 0,0% 21 
Total 301 7 2,3% 308 
 
Association statistics Symmetric Measures 
  Value df Asymp. Sig.   Value Approx. Sig. 
Pearson Chi-Square 20,359 11 0,041 Cramer's V 0,257 0,041 
Likelihood Ratio 16,991 11 0,108 N of Valid Cases 308 
  
There is no association between stage and positive test for EB (Table 4.12)  
(p > 0.7) while it is significant for ES (Table 4.13) (p≈0.003). The association index 
is, however, low (9%). Neither, results of EB or ES tests are associated with pack 
type (Table 4.14 and 4.15). 
 
Table 4.12 - Number of EB positive batches by stage 
(Bag-in-Box and Can only) 
 
Negative Positive % of +ve Total 
First 687 121 15,0% 808 
Follow up 536 92 14,6% 628 
Growth 12 1 7,7% 13 
Total 1235 214 14,8% 1449 
 
Association statistics Symmetric Measures 
  Value df Asymp. Sig.   Value Approx. Sig. 
Pearson Chi-Square 0,552 2 0,759 Cramer's V 0,02 0,759 
Likelihood Ratio 0,644 2 0,725 N of Valid Cases 1449 
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Table 4.13 - Number of ES positive batches by stage 
(Bag-in-Box and Can only) 
 
Negative Positive % of +ve Total 
First 718 90 11,1% 808 
Follow up 589 39 6,2% 628 
Growth 13 0 0,0% 13 
Total 1320 129 8,9% 1449 
 
Association statistics Symmetric Measures 
  Value df Asymp. Sig.   Value Approx. Sig. 
Pearson Chi-Square 11,865 2 0,003 Cramer's V 0,09 0,003 
Likelihood Ratio 13,291 2 0,001 N of Valid Cases 1449 
  
Table 4.14 - Number of EB positive batches by pack type 
(Bag-in-Box and Can only) 
  Negative Positive % of +ve Total 
Bag in box 708 122 14,7% 830 
Can 527 92 14,9% 619 
Total 1235 214 14,8% 1449 
 
Association statistics Symmetric Measures 
  Value df Asymp. Sig.   Value Approx. Sig. 
Pearson Chi-Square 0,008 1 0,931 Cramer's V 0,002 0,931 
Likelihood Ratio 0,008 1 0,931 N of Valid Cases 1449 
  
Table 4.15 - Number of ES positive batches by pack type 
(Bag-in-Box and Can only) 
 
Negative Positive % of +ve Total 
Bag in box 762 68 8,2% 830 
Can 558 61 9,9% 619 
Total 1320 129 8,9% 1449 
 
Association statistics Symmetric Measures 
  Value df Asymp. Sig.   Value Approx. Sig. 
Pearson Chi-Square 1,207 1 0,272 Cramer's V 0,029 0,272 
Likelihood Ratio 1,199 1 0,273 N of Valid Cases 1449 
  
Similarly to the other batches (Table 4.6 and 4.7), for the free sample 
batches there is association between the results of the tests and the years (Table 
4.16 and 4.17), particularly for ES for which the percentages of positive increase 
from 2006 to 2009 (when it reaches a maximum of 32.5%) and decrease in the 
last two years reaching a minimum of 3.6% in 2011. 
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Table 4.16 - Number of EB positive batches, by year 
(Free sample and free sample bag only) 
  Negative Positive % of +ve Total 
2006 41 4 8,9% 45 
2007 77 23 23,0% 100 
2008 51 21 29,2% 72 
2009 61 22 26,5% 83 
2010 50 9 15,3% 59 
2011 49 7 12,5% 56 
Total 329 86 20,7% 415 
 
Association statistics Symmetric Measures 
  Value df Asymp. Sig.   Value Approx. Sig. 
Pearson Chi-Square 12,345 5 0,030 Cramer's V 0,172 0,030 
Likelihood Ratio 13,152 5 0,022 N of Valid Cases 415 
  
Table 4.17 - Number of ES positive batches, by year 
(Free sample and free sample bag only) 
 
Negative Positive % of +ve Total 
2006 42 3 6,7% 45 
2007 88 12 12,0% 100 
2008 56 16 22,2% 72 
2009 56 27 32,5% 83 
2010 51 8 13,6% 59 
2011 54 2 3,6% 56 
Total 347 68 16,4% 415 
 
Association statistics Symmetric Measures 
  Value df Asymp. Sig.   Value Approx. Sig. 
Pearson Chi-Square 29,142 5 0,000 Cramer's V 0,265 0,000 
Likelihood Ratio 29,679 5 0,000 N of Valid Cases 415 
  
The association between positive tests and month (Table 4.18 and 4.19) is 
statistically significant for both, EB and ES (lower p-value for EB). The differences 
between months is much stronger here than the ones shown in the cans and 
boxes batches (Table 4.10 and 4.11), with particularly high percentages in the 
summer months. 
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Table 4.18 - Number of EB positive batches, by month 
(Free sample and free sample bag only) 
 
Negative Positive % of +ve Total 
January 23 3 11,5% 26 
February 14 2 12,5% 16 
March 30 11 26,8% 41 
April 18 6 25,0% 24 
May 17 4 19,0% 21 
June 43 10 18,9% 53 
July 32 11 25,6% 43 
August 5 11 68,8% 16 
September 43 9 17,3% 52 
October 54 10 15,6% 64 
November 25 1 3,8% 26 
December 25 8 24,2% 33 
Total 329 86 20,7% 415 
 
Association statistics Symmetric Measures 
  Value df Asymp. Sig.   Value Approx. Sig. 
Pearson Chi-Square 32,559 11 0,001 Cramer's V 0,28 0,001 
Likelihood Ratio 29,198 11 0,002 N of Valid Cases 415 
  
Table 4.19 - Number of ES positive batches, by month 
(Free sample and free sample bag only) 
 
Negative Positive % of +ve Total 
January 22 4 15,4% 26 
February 16 0 0,0% 16 
March 33 8 19,5% 41 
April 22 2 8,3% 24 
May 17 4 19,0% 21 
June 44 9 17,0% 53 
July 29 14 32,6% 43 
August 10 6 37,5% 16 
September 44 8 15,4% 52 
October 55 9 14,1% 64 
November 25 1 3,8% 26 
December 30 3 9,1% 33 
Total 347 68 16,4% 415 
 
Association statistics Symmetric Measures 
  Value df Asymp. Sig.   Value Approx. Sig. 
Pearson Chi-Square 22,676 11 0,020 Cramer's V 0,234 0,020 
Likelihood Ratio 24,229 11 0,012 N of Valid Cases 415 
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The small samples sizes and the few positive tests means that the tests 
tend to lose power. In spite of that, the relationship between positive EB tests 
and month is still weakly significant, with higher percentages positive in the 
summer months (Table 4.20 and 4.21). Both, EB and ES are associated with stage 
(Table 4.22 and 4.23). Pack type is not associated with the test results (Table 4.24 
and 4.25). 
 
Table 4.20 - Number of EB positive batches, by month 
(Free sample and free sample bag only) 
(from may 2010 - latest 18 months) 
 
Negative Positive % of +ve Total 
January 3 0 0,0% 3 
February 3 0 0,0% 3 
March 1 0 0,0% 1 
April 8 0 0,0% 8 
May 7 0 0,0% 7 
June 25 3 10,7% 28 
July 5 1 16,7% 6 
August 1 3 75,0% 4 
September 14 6 30,0% 20 
October 10 0 0,0% 10 
November 4 1 20,0% 5 
December 3 0 0,0% 3 
Total 84 14 14,3% 98 
 
Association statistics Symmetric Measures 
  Value df Asymp. Sig.   Value Approx. Sig. 
Pearson Chi-Square 22,361 11 0,022 Cramer's V 0,478 0,022 
Likelihood Ratio 21,971 11 0,025 N of Valid Cases 98 
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Table 4.21 - Number of ES positive batches, by month 
(Free sample and free sample bag only) 
(from may 2010 - latest 18 months) 
 
Negative Positive % of +ve Total 
January 3 0 0,0% 3 
February 3 0 0,0% 3 
March 1 0 0,0% 1 
April 8 0 0,0% 8 
May 7 0 0,0% 7 
June 28 0 0,0% 28 
July 5 1 16,7% 6 
August 4 0 0,0% 4 
September 17 3 15,0% 20 
October 10 0 0,0% 10 
November 5 0 0,0% 5 
December 3 0 0,0% 3 
Total 94 4 4,1% 98 
 
Association statistics Symmetric Measures 
  Value df Asymp. Sig.   Value Approx. Sig. 
Pearson Chi-Square 11,581 11 0,396 Cramer's V 0,344 0,396 
Likelihood Ratio 11,109 11 0,434 N of Valid Cases 98 
  
 
Table 4.22 - Number of EB positive batches by stage 
(Bag-in-Box and Can only) 
 
Negative Positive % of +ve Total 
First 687 121 15,0% 808 
Follow up 536 92 14,6% 628 
Growth 12 1 7,7% 13 
Total 1235 214 14,8% 1449 
 
Association statistics Symmetric Measures 
  Value df Asymp. Sig.   Value Approx. Sig. 
Pearson Chi-Square 0,552 2 0,759 Cramer's V 0,02 0,759 
Likelihood Ratio 0,644 2 0,725 N of Valid Cases 1449 
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Table 4.23 - Number of ES positive batches by stage 
(Bag-in-Box and Can only) 
 
Negative Positive % of +ve Total 
First 718 90 11,1% 808 
Follow up 589 39 6,2% 628 
Growth 13 0 0,0% 13 
Total 1320 129 8,9% 1449 
 
Association statistics Symmetric Measures 
  Value df Asymp. Sig.   Value Approx. Sig. 
Pearson Chi-Square 11,865 2 0,003 Cramer's V 0,09 0,003 
 
Table 4.24 - Number of EB positive batches by pack type 
(Free sample and free sample bag only) 
  Negative Positive % of +ve Total 
Free sample bag 306 80 20,7% 386 
Free sample bag in box 23 6 20,7% 29 
Total 329 86 20,7% 415 
 
Association statistics Symmetric Measures 
  Value df Asymp. Sig.   Value Approx. Sig. 
Pearson Chi-Square 0,000 1 0,996 Cramer's V 0,000 0,996 
Likelihood Ratio 0,000 1 0,996 N of Valid Cases 415 
  
Table 4.25 - Number of ES positive batches by pack type 
(Free sample and free sample bag only) 
 
Negative Positive % of +ve Total 
Free sample bag 321 65 16,8% 386 
Free sample bag in box 26 3 10,3% 29 
Total 347 68 16,4% 415 
 
Association statistics Symmetric Measures 
  Value df Asymp. Sig.   Value Approx. Sig. 
Pearson Chi-Square 0,830 1 0,362 Cramer's V 0,045 0,362 
Likelihood Ratio 0,925 1 0,336 N of Valid Cases 415 
  
 
The evidence of association between product types and contamination is 
variable (Table 4.12, Table 4.13, Table 4.22, Table 4.23), and indicated associa-
tions are weak. Overall, at least to a first approximation, it seems reasonable to 
neglect differences between product types. There is no significant evidence of 
differences between packaging formats (Table 4.14, Table 4.15, Table 4.24, Table 
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4.25). At least to a first approximation, it seems reasonable to neglect differ-
ences between packaging formats.  
There is strong evidence of substantial reductions in contamination levels 
in 2011, so that it may be misleading to apply quantitative conclusions based on 
earlier years to later production. There is also evidence that contamination levels 
are higher in the summer than the winter (Table 4.10, Table 4.11, Table 4.20, Ta-
ble 4.21). Those differences between months and between years are differences 
in overall contamination levels between groups of many batches, averaged 
across those groups.  
 
Moreover, from this data it is impossible to know anything about the with-
in-batch distribution. We have, however, some data on sublot sampling that can 
shed some light on this aspect. 
For 42 of the batches analyzed in the sublot analysis, we have the se-
quence in time of the results of the pallet testing (832 pallets). From this data we 
can see the spatial distribution of positive and negative pallets within the batch. 
If pallets within the batch are clustered, positive would be, more often than not, 
be followed by positive and the same for negatives. This would give an associa-
tion between the result at time t and the result at time t-1. The data can be 
summarized by a 2 x 2 contingency table (Table 4.26): 
Table 4.26 – Sub-lot testing: association between ES  
results for pallets and preceding pallets 
    pallet t   
    negative positive total 
pallet t-1 
Negative 244 82 326 
Positive 79 385 464 
 
Total 323 467 790 
 
We ran a chi-square test and the result is: 
Chi-square test 
  Value df p-value 
Chi-Square 264,8567 1 < ,000 
Phi 0,579 1  
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The association within the batches between the result at time t and the re-
sult at time t-1 is highly significant and this shows that there is clustering within 
batches. 
 
The analysis performed on the available data clearly show that the conclu-
sions reached by the control quality organization are, at best, only partially ac-
ceptable and quite often wrong. With the data on the sublot analysis we have 
proved the presence of clustering within batches. In such situation the uniform 
Poisson model is not adequate to describe the distribution of CFU inside the 
batch. As already said, the literature on the subject affirms that in most situa-
tions a Poisson LogNormal distribution seems to be more adequate to model the 
amount of microorganisms in aliquots of milk powder. Furthermore, the assump-
tion of identical batches was clearly rejected by our analysis and since most of 
the data are across batches it is impossible to give an answer to all the questions 
posed by ACME.  
As seen above, it is impossible to state that a sampling strategy is better 
than another (it depends on the spatial distribution of the CFUs inside the batch). 
An additional problem is due to the particular way the sample is drawn in the 
ACME sampling procedure that make it different from the usual systematic sam-
pling.  Drawing 10g every two minutes, we get 1.53 Kg of powder, from which, 
after intense mixing, only 300g are finally collected and analyzed. In the final 
stage the aliquots are thus remade and obviously only some of them will be con-
taminated. The number of aliquots contaminated will depend on the number of 
CFU present in the 1.53 kg of powder and on chance (allocate m CFU in k ali-
quots). This is the classical “occupancy problem” (Feller, 1968), complicated by 
the fact that m can assume values 0, 1, 2, …, that allows the computation of p, 
the probability that an aliquot is contaminated, and finally the probability that 
the sample is contaminated through the binomial distribution. The wide variety 
of situations that can arise make the analytical solution of this problem quite 
complex.  
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We therefore decided to tackle the problem by simulating the sampling 
process on a set of 100,000 batches generated by a Poisson Lognormal distribu-
tion. The simulations compute both the probability of detection of a contaminat-
ed batch and the residual risk of in-market positive Law Sampling. On the basis of 
the standard deviation value of 0.69539082 estimated by FAO/WHO (see Table 
4.27) and imposing a probability of detection equal to 8.14% on the full produc-
tion, the mean concentration level characterizing all the batch produced by AC-
ME can be computed. 
 
Table 4.27 – Calculated concentration values based on published studies in the scientific litera-
ture and unpublished studies provided to FAO/WHO on the frequency of E. Sa-
kazakii contamination of PIF (FAO/WHO, 2006). 
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To do that, it was firstly implemented the “finder” function in order to find 
the mean concentration level of the PLN that minimizes the square deviation be-
tween the probability of discarding the batch ( = 1 - PLN(0)^30 ) and the desired 
probability of detection. 
The simulation scheme was firstly implemented assuming that all batches 
are contaminated and the probability of detection equals the one found with our 
testing procedure (8.14%).  The simulation then moves to more realistic schemes 
which assume progressive smaller fraction of contaminated batches (30%, 20%, 
10% to arrive at the minimum value 8.14%). For example, if we hypothesize that 
only 30% of the batches is contaminated, the probability of detection for the 
contaminated batches rises to 27.133%, because 0.27133333 x 0.30 + 0 x 0.70 = 
0.0814. In this case the mean concentration level of the contaminated batches is 
equal to -5.782467. 
 
library(VGAM) 
finder = function(y,a){ 
# sdlog on std FAO 
pln0=dpolono(0,meanlog=y, sdlog=1.60119652566498) 
return ( (1-pln0^30-a)^2 ) 
} 
 
opt=optimize(finder, c(-30,0), a=.27133333) 
opt 
 
> opt 
$minimum 
[1] -5.782467 
$objective 
[1] 1.357951e-13 
 
Independently from the actual spatial distribution of CFUs (impossible to 
recreate because of the absence of information on its shape), each batch is com-
putationally recreated in vectorial mode, simulating the actual serialization of 
the product during the processing line (the time in which the process of Au-
tosampling starts). 
The batch reproduced in the simulations is a batch of 4.5 tons (450,000 10g 
aliquots). The code attached below simulates the configuration of a contaminat-
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ed batch when only 30% of the produced batches is contaminated, randomizing 
the inside distribution of the CFUs. 
 
tot.cub=450000 
res=dpolono(0:1000,meanlog=-5.782467, sdlog=1.60119652566498)   
expect=round(res*tot.cub,0) 
names(expect)=0:1000 
expect=expect[expect>0] 
 
serializz=NULL 
for (i in 1:length(expect)) 
       serializz=c(serializz,rep(i-1,expect[i])) 
serializz=c(serializz, rep(0,tot.cub-length(serializz))) 
# randomizzazione degli aliquots 
serializz=serializz[ order(runif(length(serializz))) ] 
 
For each of the hypothesized configurations of contamination (share of 
contaminated batch equal to 100%, 30%, 20%, 10, 8.14%), it was deemed neces-
sary to make assumptions on the concentration of CFU within the batches, com-
paring patterns of random distribution with more realistic patterns of clustering. 
Based on the information supplied by the technicians of ACME, the distribution 
of CFUs in the case of clustering has been hypothesized of descending intensity 
starting from the center of the cluster. This configuration has been simulated by 
means of a function with the unique purpose of increasing the realism of the 
simulations; from a purely computational point of view, this distribution assump-
tion does not affect in any way the outcome of the simulations, as the tests are 
based on positivity of the sampled aliquot (and not on the actual number of CFU 
present in it).  
   
It was therefore implemented a generalized function that, for each of the 
hypothesized odds of contamination and types of distribution, is able to compare 
the performance of five different sampling strategies in identifying contaminated 
batch, extracting 30 aliquots of 10 grams from each batch. 
The five different sampling strategies are: 
- Random sampling (Random or Law test): 30 aliquots are taken at ran-
dom, using the urn scheme (drawing 30 values from a vector of indices 
of length 450,000); 
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- Systematic sampling (SYS): 30 aliquots are drawn selecting the first at 
random from the block of aliquots 1 – 15,000 and then selecting the 
others with the 15,000 step; 
- ACME sampling (ACME300gr): an aliquot of 10gr is sampled every 2 
minutes. In  2 minutes ACME is able to package 84 cans of 350g, it 
means manage 2,940 10gr aliquots. In other words, one aliquot is drawn 
at random from the block of aliquots 1 – 2,940 and the others are se-
lected with the 2,940 step. In this way, we get 1,530gr of powder (153 
10g aliquots). After well mixing this amount of powder, 300g of product 
are randomly selected for testing. The simulation of this last drawing 
was carried out using a self-generated algorithm that solved the Occu-
pancy Problem mentioned earlier; 
- Stratified sampling (STR random): 30 aliquots are sampled at random 
one in each of the 30 blocks of 15,000 aliquots;  
- ACME stratified sampling (STR-ACME.random300gr): this sampling 
strategy is similar to ACME300gr with the difference that the aliquots 
are not systematically sampled but they are drawn at random, one for 
each of the 153 block of 2,940 aliquots. Even in this case, the amount of 
1,530gr of powder is well mixed and 300g is randomly selected for test-
ing. 
The simulation scheme was then repeated assuming a probability of detec-
tion equal to 2.3% (the observed probability in the latest 18 months of produc-
tion). 
 
Results of the whole simulation process are shown in Table 4.28 and Table 
4.29. Irrespective of the starting probability of detection (8.14% or 2.3%) and the 
different rates of contaminated batches (100%, 30%, 20%, 10% and the limiting 
case) no sampling schema is clearly prevalent in all situations. It is important to 
underline the fact that how the systematic sampling can be much worse of the 
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other sampling schemes due to the amount of overlapping while the improve-
ment in case of no overlapping is rather limited
5
. The stratified random sampling 
can be a compromise between random and systematic sampling even if the im-
provement with respect to random sampling is quite low. 
  
Table 4.28 – Simulation results for different hypothesis on the distribution of the contaminated 
aliquots and the five analyzed sampling strategies (considering a probability of 
detecting positive batches equal to 8.14%) 
 
 
                                                          
 
 
5
 As expected, in case of perfect overlapping (with SYS step) with contamination in only two clus-
ter, the probabilities of detection for the systematic sampling is about one half of the same prob-
abilities computed with the other sampling schemes. In the same situation, instead, the disad-
vantages of the systematic drawing characterizing the ACME sampling are partially compensated 
by the random drawing of the final 300g of powder carried out after the last mixing. 
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Table 4.29 – Simulation results for different hypothesis on the distribution of the contaminated 
aliquots and the five analyzed sampling strategies (considering a probability of 
detecting positive batches equal to 2.3%) 
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4.4 Conclusions 
The simulation results do not help us in answering all the ACME questions; as 
commented above, we can give some suggestions on the best sampling schemes: 
systematic sampling is certainly a risky procedure and in our opinion, if technical-
ly feasible, should be avoided in favor of some random scheme. We cannot, 
however, say anything on the residual risk of in-market positive Law sampling.  
The simulations show that with the same probability of detecting the origi-
nal contaminated batches, we can get very different percentages of contaminat-
ed aliquots in the released batches. The simplistic assumption of a PLN distribu-
tion for the number of CFU in all aliquots of the different batches does not solve 
our problems: all the batches would be contaminated and all should not be re-
leased on the marked (absurd). What is then a more realistic distribution? The 
assumption of zero inflated distributions hypothesized in some of our simula-
tions is certainly more realistic. Unfortunately, even if this assumption were true, 
we do not know the zero inflation factor. To conclude, to say something on the 
characteristics of the released batches and hence on the efficacy of the lot by lot 
acceptance sampling, we would need to know much more on the spatial distribu-
tion within the batch and, even more important, the distribution between batch-
es. This is the reason that suggested to abandon the approach followed by the 
quality control organization, as well as by the  literature on the subject, and to 
propose a completely new and innovative one that will allow to answer all the 
questions posed by ACME. 
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5 – A NEW APPROACH FOR THE DETECTION OF ES IN THE PIF  
PRODUCTION 
 
 
 
 
 
 
 
5.1 A new approach 
Since we could not answer the questions posed by ACME with the procedures 
described in the previous chapters we will try to answer the same questions by a 
completely different approach. 
It is well known that sensitivity and specificity are the most widely used 
statistics to describe a diagnostic test. In our case, the sensitivity is the probabil-
ity that the test is positive when the batch is contaminated while the specificity is 
the probability that the test is negative when the batch is not contaminated. 
What is the meaning of “contaminated”? To make things clearer we will use 
wording such as “ES is present in the batch analyzed” even if “contaminated” for 
us means simply that the batch would not be released on the market if the firm 
had a perfect knowledge regarding the concentration of ES. Obviously, “not con-
taminated” means that the firm, with perfect knowledge, would release the 
batch. This is a necessary clarification since some people believe that at least a 
few CFU are always present in every batch. ACME management does not think 
so, but we do not care who is right, as long as a clear definition of “contaminated 
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batch” is given. The definition could be “at least one CFU is present in the batch” 
or “the concentration of CFU is above the detection limit” or any other defini-
tion.  
 
Since in the following we are going to estimate the probability of many dif-
ferent events, some notation is necessary: 
T+  = the test is positive, ie. ES was found in the milk powder of the batch 
analyzed; 
T- = the test is negative, ie. ES was not found in the milk powder of the 
batch analyzed; C = the batch is contaminated (ES is present in the powder of the batch 
analyzed); C_ = the batch is not contaminated 
 
 To answer the questions posed by ACME we would need to know, or, more 
realistically, estimate from the available data, the sensitivity and specificity of the 
tests performed under the different sampling schemes. 
The estimate of the sensitivity and specificity of a test together with the a priori 
probability, in our case (`), would also allow the estimates of the posterior 
probabilities, through the usual Bayes formulas: 
 
 
(`/bc) = (`) ∙ (bc/`)(`) ∙ (bc/`) + (`̅) ∙ (b/`̅) 
and  
(`̅/b) = (`̅) ∙ (b/`̅)(`̅) ∙ (b/`̅) + (`) ∙ (bc/`) 
 
If a test has high sensitivity and high specificity, these probabilities would be very 
close to one and hence the test would be very reliable.  
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Among the available data there are some laboratory tests (called analytical 
validation tests) in which the tests were carried out to validate the ACME Lab 
test. These tests were performed on contaminated and not contaminated pow-
der; i.e. in these tests the knowledge regarding the presence or absence of ES in 
the powder was perfect. In total we have 68 tests on contaminated powder and 
97 on ES-free powder. Both sensitivity and specificity were equal to 100% i.e. the 
estimate of (bc/`) and of (b/`̅) were both equal to one. This does not im-
ply that the lab tests are 100% sure since these are only estimates of the true 
probabilities based on a random sample, and the same results could have been 
obtained even if the two mentioned probabilities had been less than one. To 
measure the precision of our estimates we could compute a confidence interval 
for the two probabilities. Unfortunately, the usual formulas used in constructing 
a confidence interval for proportions cannot be used since the estimates of (bc/`) and of (b/`̅) are both equal to one and hence it is not possible to 
estimate the variances of the estimators (they would both be equal to zero). We 
can solve the problem using the Wilson Score interval (Wilson, 1927): 
 
̂ + 12 fg/ ± fg/i̂(1 − ̂) + fg/4
1 + 1 fg/  
 
obtaining the following interval: 
  95% confidence interval 
 Estimation Lower limit Upper limit (bc/`) 1 0,9465 1 (b/`̅) 1 0,9619 1 
 
The confidence intervals have been computed only to evaluate the preci-
sion of the estimates. Notice, however, that the estimates are not, as normally 
happens, the midpoint of the intervals, but they are both equal to one. These 
probabilities, however, are estimated in a laboratory setting and they should be 
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revised if we operate in the field since they will be affected by the sampling crite-
ria. 
 
Even if the lab test were perfect (100% sensitivity and specificity), the ran-
dom drawing of the powder to be analyzed could change the sensitivity (not the 
specificity) of the test performed, since (bc/`) depends both on the precision 
of the lab test and on the capacity of the random drawing to intercept the con-
taminated powder if present. The way we draw the powder is hence very im-
portant: a batch could be contaminated, but the sample drawn is ES-free. A fur-
ther complication is due to the fact that we do not know the so called prior 
probabilities, i.e. the probability that ES is present in a batch.  
 
In order to answer the questions posed by ACME, we will assume that sen-
sitivity and specificity of the lab test are equal to their estimates obtained in the 
analytical validation tests i.e. they are set equal to 1. 
 
With this approach we will try to answer the questions directly with the da-
ta we have, making a few assumptions. The main assumption is the following: if a 
test, either the ACME test or the Law test, is positive, then the batch is “contami-
nated”. The assumption has some rather strong implications; the following 
statements are all equivalent to our assumption:  
a) there are no false positives;  
b) the probability that the batch is contaminated when we get a positive test 
is equal to one (we could relax our assumption a little by saying that this 
probability is “close to one” and if we work assuming that is equal to one, 
our conclusions will be approximately true)  
c) if a batch is not contaminated the test cannot be positive, i.e. the proba-
bility that that the test is positive when the batch is not contaminated is 
equal to zero (we could assume that it is close to zero, with the same con-
siderations made above).  
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To make things easier, let us start with some notation: 
A+ test positive with ACME sampling (Autosampling plus retesting) 
carried out only on the original batches 
L+ test positive with law-sampling on the original batch 
L+on A- test positive by Law-sampling carried out on released batch 
(original batches that tested negative by Autosampling and were 
released on the market). This test is carried out by the authori-
ties. 
C batch is contaminated (there is at least one Sakazaky bacterium 
in the batch) C_ batch is not contaminated 
CR the set of contaminated batches released on the market (these 
batches tested negative by Autosampling and were - wrongly - 
released on the market) 
CS the set of contaminated batches in the sublot analysis (it is really 
redundant since all the batches in the sublot analysis are con-
taminated - they tested positive by Autosampling - however 
some of the pallets may not be) 
 
Notice the unusual notation L+on A- to denote the conditional event “posi-
tive Law-test performed on the batches that tested positive in the Auto-test. We 
will often use this notation because we feel that sometimes it is more clear. 
If ES is not present in the batch of powder, the two testing procedures are equiv-
alent since they depend only on the lab tests. Autosampling is then better than 
Law-sampling if ((c/`) > (kc/`). 
 
The probability (C) is unknown; the only thing we know is that (C) ≥ ((c), given the assumption made above. Now, 
-  (c = ((c ∩ `) ∪ ((c ∩ `̅) i.e. the ACME procedure will test positive 
and the batch is contaminated or it will test positive and the batch is un-
contaminated. Our assumption implies that the second case is not possi-
ble or, at least, the probability that a not contaminated batch tests posi-
tive is so close to zero that we can assume that it is equal to zero. So we 
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will assume that ((c ∩ `̅) = 0 ⇒ E(nc) = E(nc ∩ o) = E(o) ∙E(nc/o); 
- kcp( = qkcp(! ∩ `rs ∪ qkcp(! ∩ `r̅s i.e. Law testing on re-
leased batches can be positive and the batch is contaminated or can be 
positive and the batch is not contaminated. Again we exclude this second 
possibility, that is, we assume qkcp(! ∩ C_ts = 0 and hence 
 EucJvn! = qkcp(! ∩ Cts = E(wx) ∙ EqucJvn!/wxs 
But  we know that 
(`r) = (`) ∙ ((/`) = (`) ∙ W1 − ((c/`)X 
and hence 
kcp(! = (`r) ∙ qkcp(!/`rs = (`) ∙ W1 − ((c/`)X ∙ qkcp(!/`rs 
If we take the ratio 
kcp(!((c) = W1 − ((c/`)X ∙ qkcp(!/`rs((c/`)  
and so, after some algebra, we get 
((c/C) = ((c) ∙ qkcp(!/Ctskcp(! + ((c) ∙ qkcp(!/Cts 
If we could estimate this last equation we would have solved all our prob-
lems since the left hand side of the equation is the sensitivity of the ACME test-
ing procedure, that is, its effectiveness. 
Notice now that: 
- ((c) can be estimated from the data on testing the original batches; 
- kcp(! can be estimated from the data on inspectors’ testing; 
- qkcp(!/Cts cannot be estimated directly from data on released 
batches, but something can be done with the data on the sublot analysis 
(as we can see below). 
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Once ((c/C) is estimated we can estimate (C) by 
y(C) = y(Ac)y(Ac/C) 
It may seem strange that we will be able to estimate the probability of C 
without even defining it. Take into consideration, however, that we have implic-
itly defined C by saying that (Ac/C_) = 0 or, equivalently, (C/Ac) = 1. If we 
believe that practically all batches, even the cleanest, have some CFU, we are 
saying that a batch is not contaminated if the number of CFU is so small that the 
probability that it tests positive is zero or reasonably close to zero.  
Unfortunately the data we have does not allow the estimation of (Ac/C), 
since we do not know qkcp(!/Cts. This probability can be estimated using 
the sublot sampling. We have data on 113 batches that tested positive with Au-
tosampling plus retesting and for which a later analysis on pallets was carried 
out: for these we know the number of pallets tested (all the pallets of the batch 
were tested) and the number of positive pallets.  
Every batch in the sublot sampling tested positive with the ACME proce-
dure; hence all the batches were contaminated. Some boxes (4 big cans, 6 small 
ones or 12 bags in the old batches) were drawn from every pallet (really a crate 
was chosen and crates have 4 or 6 cans or 12 bags), the powder of the crate of 
the pallet was mixed and 300 grams was tested. If at least one pallet tested posi-
tive, the batch tested positive with sublot sampling. The testing on the batch was 
hence carried out on powder taken from a variable number of cans (calling 
“cans” also the bags), and a variable weight of the powder analyzed (300g multi-
plied by the number of pallets). Law testing on the released batches is instead 
done by randomly drawing 30 cans from the batch (sometimes the cans could be 
drawn from part of the batch), mixing the powder and analyzing 300grams.  
We tried to estimate qkcp(!/Cts, by first estimating qkcp(c!/C{s 
from the data on sublot sampling. This was accomplished in two steps: first re-
ducing the number of cans drawn to 30. Drew randomly a number of pallets in 
each batch to get exactly 30 cans. In order to get 30 cans we have to draw 2.5 
pallets if crates are made of 12 bags, 5 pallets if 6 can crates and 7.5 pallets if 4 
can crates. To draw 2.5 and 7.5 pallets, 2 and 7 pallets were first drawn and then 
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another was drawn with probability 0.5. At the end of this drawing, a certain 
percentage of batches tested positive.  
The problem now is that we have drawn 30 cans from every batch but the 
amount of powder analyzed is not 300 grams, as required by law testing, but 
300g multiplied by the number of pallets drawn. So, secondly, a logit model was 
applied to the data: the result of the acceptance test as the dependent variable 
and the amount of powder analyzed as the only explicative variable. Finally the 
forecast for the dependent variable (the estimate of the percentage of positive 
batches with law testing) was obtained by setting the amount of powder equal to 
300g in the estimated model.  
This procedure was repeated ten thousand times and the average was tak-
en as our final estimate. The drawing was carried out both with and without re-
placement getting, obviously, almost the same results. Drawing with replace-
ment was finally chosen because it is in line with bootstrap techniques that allow 
the estimation of the distribution of the estimator and the construction of a con-
fidence interval. 
The final result of this procedure is the estimation of qkcp(c!/C{s, 
where C{ is the set of contaminated batches in the sublot analysis. In actual fact 
all batches in the sublot analysis are contaminated: we did not use C because (C) < 1 while (C{) = 1. We will assume that  
qkcp(c!/C{s = qkcp(!/Cts 
The weak point of this reasoning is the usual one: both probabilities refer 
to contaminated batches, but the contaminated batches in the sublot analysis 
(C{) tested positive by ACME procedure and hence presumably have a higher 
concentration of bacteria than the contaminated batches (Ct) that tested nega-
tive using the same procedure. Furthermore, sublot sampling is not completely 
random: with our procedure we randomly drew some pallets and then drew 
some cans. Sampling is hence “weakly” systematic. The final estimate reported 
below is probably an overestimate of the intended probability (batches in the 
sublot sampling have a higher concentration of bacteria that increase the proba-
bility of testing positive and sampling is systematic that could increase or de-
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crease this probability). A better way to estimate it in the future will be proposed 
in the next chapter.  
With this assumption and the results of the described simulation, we can 
compute: 
qkcp(!/Cts = 0.675 3ℎ  95% -1240-0 30L5 W0.575, 0.771X 
The available data give us the results of acceptance sampling from May 
2006 to October 2011, more than 5 years of testing for a total of 1449 batches. 
Of these 129 tested positive either with the 300g testing or the successive 750g 
testing. The estimate of ((c) = 0.089 with a 95% confidence interval  
[0.0744, 0.1037]. 
Finally, we have the results on inspection testing by the authorities: in the 
more than 5 years of testing the inspectors carried out at least 600 (probably 
more than 700) tests, none positive. 
The following table summarizes the various probabilities: 
  95% confidence interval 
 Estimation Lower limit Upper limit ((c) 0.089 0.0744 0.1037 qkcp(!/Cts 0.675 0.5750 0.7710 
 
From the information on the authorities testing we get: 
  95% confidence interval 
 Estimation Lower limit Upper limit kcp(!  (n=500) 0 0 0.0076 kcp(!  (n=600) 0 0 0.0064 kcp(!  (n=700) 0 0 0.0055 
 
where these last probabilities were computed with the Wilson score interval. 
These last probabilities really answer the question on the residual risk that 
a lot released applying the ACME procedure will be found positive by the author-
ities applying the Law sampling procedure. The estimate is zero but the 95% con-
fidence interval gives a maximum risk of 0.0076 if n = 500 (or 0.0055 if n = 700). 
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Finally, applying the formula found above 
((c/C) = ((c) ∙ qkcp(!/Ctskcp(! + ((c) ∙ qkcp(!/Cts 
we can compute the sensitivity of the ACME test. The estimations of the various 
probabilities in the best and worst possible cases are reported below: 
E(nc) EqucJvn!/wxs EucJvn! E(nc/w)  
0.0890 0.6750 0 1 best case 
0.0744 0.5750 0.0076 0.8490 worst case 
 
The estimate of the sensitivity of the ACME testing procedure, with our as-
sumptions, is 1 i.e. perfect testing. In the worst situation i.e. assuming that two 
of the computed probabilities are at the lower end of the confidence interval and 
the kcp(! is at the upper limit we get sensitivity equals to 0.849. Take into 
consideration, however, that qkcp(!/Cts  could be overestimated. Finally, 
an estimate of (C) is 
y(C) = y(Ac)y(Ac/C) = 0.089  3ℎ  130 90% -1240-0 30L5 W0.074, 0.119X2  = 600 
Take into consideration, however, that this refers to the average of the last 
six years; today the situation is much improved and the probability of the batch 
testing positive with ACME procedure in the last eighteen months is just above 
2% with a similar improvement for (C). However, since it refers only to con-
taminated batches, the (Ac/C) may be unchanged.  
To conclude, the questions that can be answered with this approach are:  
1. Is ACME Sampling better than Law Sampling and, if yes, how much 
better? The estimate of the sensitivity of ITACME sampling process is 
1, i.e. all contaminated batches are identified by ACME sampling and 
are not released on the market. Naturally, this is the point estimate; 
in the least favorable situation, the sensitivity of ITACME sampling is 
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equal to 0.849. We do not have a direct estimate of the sensitivity of 
Law sampling. From the data on the sublot analysis we estimated a 
sensitivity of 0.675, giving ACME sampling a 48% advantage over Law 
sampling. The advantage is probably much greater considering that 
the sensitivity found for Law sampling, as already stated, is probably 
overestimated.  
 
2. What is the residual risk of in-market positive Law Sampling?  
From the samples taken by the authorities, the estimate of the resid-
ual risk of Law Sampling testing positive is zero with a 95% confi-
dence interval [0% - 0.76%].  
5.2 Conclusions 
From our new analysis and the results of the simulations of chapter 4 we can 
conclude that ACME sampling is certainly superior to Law sampling, most proba-
bly due to the greater quantity of powder analyzed by the first method and not 
to the sampling procedure. In point of fact, without the retesting that further an-
alyzes 750 g of powder in presence of positive test to the bacteriaceae, ACME 
sampling is just slightly better in the best situation (no or very small overlapping 
of the contaminated areas), but can be much worse. 
Since the tests carried out by the Authorities give an estimation of the re-
sidual risk equal to 0% with the sample size of 500 – 700, the real rate of contam-
ination should be pretty close the limiting one.   
A weak point of our new approach is the estimation of qkcp(!/Cts 
that was quite elaborate and that probably provided an overestimation of this 
probability. In the next chapter, we will propose the collection of new data that 
will, at least partially, overcome this problem and that will give better answers to 
all the question submitted by ACME. 
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6 – PROPOSALS FOR THE FUTURE  
 
 
 
 
 
 
 
 
In the previous chapter we estimated all the relevant probabilities (the most im-
portant was the sensitivity of ACME testing procedure) making an assumption 
that allowed the estimation (really overestimation) of 
 qkcp(!/Cts. We are now going to propose some further testing on a cer-
tain number of batches that would allow the elimination of the mentioned as-
sumption, with the substitution of a much weaker one. 
Our proposal to ACME was to test the original batches for an adequate pe-
riod of time by both sampling procedures. We suggested to collect data by test-
ing a certain number of batches also by Law sampling, so we can also estimate (k+).  
As we saw above, tests of this kind were carried out in ITACME in 2006 on 
only 41 batches and we were able to prove a difference between the two testing 
procedures; the confidence interval for this difference was, however, too wide.  
A larger sample is certainly needed, but the decision on how large the sample 
should be can be delayed: we can follow a sequential testing procedure where 
the sample size is not fixed in advance. Instead the data are evaluated as they 
are collected, and further sampling is stopped in accordance with a pre-defined 
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stopping rule as soon as significant results have been observed. - a recognized 
and pragmatic approach. After that, a second Law testing should be carried out 
only on the set that tested differently by the two testing procedures (presumably 
very few. Obviously, released batches will be Law tested by the authorities. It is 
difficult to decide how many batches should be tested with Law testing since the 
right number depends on the probability of positive tests, on the difference be-
tween ((+) and (k+) and on the precision we would like to have. 
If we assume, as was done in the previous chapter, specificity equal to 1, 
i.e. 
((c/C_) = (kc/C_) = 0 ⇔ (C/(c) = (`/kc) = 1 
then 
((c)(kc) = (C) ∙ ((c/C)(C) ∙ (kc/C) = ((c/C)(kc/C) 
will give an estimate of how much better ACME procedure is in terms of the sen-
sitivity of the two testing procedures. If the difference between the two testing 
procedures is noticeable (like the 41 batches tested in ITACME in 2006), an ade-
quate sample should not take more than a year. This, together with some testing 
done on the released batches would answer most of ACME questions.  
To summarize our proposal consider all the possible results of the two test-
ing procedures and their consequences: 
1. If A+ and L+ the batch is rejected; 
2. If A- and L– the batch is released (authorities will carry out Law tests on 
these batches); 
3. If A- and L +  or A+ and L –  the batch is rejected and we propose to perform 
another Law test on these batches.  
 
Denote by 
kcp( = Law test positive on batches that tested negative to Autosampling kcpk= Law test positive on batches that tested negative to Law sampling 
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Now,  
kcp(! = C! ∙ qkcp(!/Cs= (C) ∙ W1 − ((c/`)X ∙ qkcp(!/Cs 
where `  = set of contaminated batches that tested negative to Autosampling, and 
kcpk! = C! ∙ qkcpk!/Cs= (C) ∙ W1 − (kc/`)X ∙ qkcpk!/Cs 
where ` = set of contaminated batches that tested negative to Law sampling.  
In order to estimate the complete set of probabilities involved, we shall as-
sume that qkcp(!/ `s = qkcpk!/`s. This is the weaker assumption 
that substitute the stronger one made in the previous paragraph. The assump-
tion regards two sets of batches, both contaminated. 
This, again, could raise the objection that C  has a different level of con-
centration than C  due to the more effective Autosampling with respect to Law-
sampling. The difference, however, should not be relevant. So, we would have 
the following equations: 
1) ((c) = (C) ∙ ((c/C) 
2) (kc) = (C) ∙ (kc/C) 
3) kcp(! = (C) ∙ W1 − ((c/C)X ∙ qkcp(!/Cs 
4) kcpk! = (C) ∙ W1 − (kc/C)X ∙ qkcp(!/Cs 
We have 4 equations in 4 unknowns:  (C), ((c/C), (kc/C), qkcp(!/Cs. Denote by: 
(C) =  
and 
((c) =  ((c/C) =  (kc) = / (kc/C) =  kcp(! = - qkcp(!/Cs =  kcpk! = 4 
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, /, -, 4 can be estimated and , , ,  are the unknowns.  
The 4 equations are now written: 
1)  =  ∙  
2) / =  ∙  
3) - =  ∙ (1 − ) ∙  
4) 4 =  ∙ (1 − ) ∙  
 
Solve by substitution:  
1)  =  
2)  =  =  =   
3) - =  (1 − ) ⇒  = A() = A = A 
4) 4 =  1 −   A() =  ∙ A = A ∙  ⇒ - − /- − 4 +4 = 0 ⇒  = AA  -1  ≠ 0 0  ≠ 1. 
So: 
1)  =  =   = AA = AA  
2)  = ∙(A)A  
3)  =   =  ∙ AA = AA = ∙(A)A  
4)  = A ∙  = A ∙      = A ∙ AAA = AAAA = A  
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Coming back to original variables: 
 
1) ((c/C) = ()∙q&!&!s()∙&!()∙&! 
2) (kc/C) = ()∙q&!&!s()∙&!()∙&! 
3) qkcp(!/Cs = &!&!()()  
4) (C) = ()∙&!()∙&!&!&!  
 
In conclusion, with the proposed testing we can: a) estimate the sensitivity 
of ACME and Law testing procedures and hence allow the comparison of their ef-
fectiveness; b) directly estimate the residual risk on the released batches; c) es-
timate the probability of contamination. 
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4. Poisson LogNormal (PLN) distribution 
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